ID ANFY1_HUMAN STANDARD; PRT; 1169 AA. AC Q9P2R3; Q9ULG5; DT 04-AUG-2003, integrated into UniProtKB/Swiss-Prot. DT 04-AUG-2003, sequence version 2. DT 18-APR-2006, entry version 34. DE Ankyrin repeat and FYVE domain-containing protein 1 (Ankyrin repeats DE hooked to a zinc finger motif). GN Name=ANKFY1; Synonyms=ANKHZN, KIAA1255; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, AND TISSUE RP SPECIFICITY. RC TISSUE=Fetal brain; RX MEDLINE=20400338; PubMed=10940552; DOI=10.1016/S0378-1119(00)00247-X; RA Kuriyama H., Asakawa S., Minoshima S., Maruyama H., Ishii N., Ito K., RA Gejyo F., Arakawa M., Shimizu N., Kuwano R.; RT "Characterization and chromosomal mapping of a novel human gene, RT ANKHZN."; RL Gene 253:151-160(2000). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND TISSUE SPECIFICITY. RC TISSUE=Brain; RX MEDLINE=20039619; PubMed=10574462; DOI=10.1093/dnares/6.5.337; RA Nagase T., Ishikawa K., Kikuno R., Hirosawa M., Nomura N., Ohara O.; RT "Prediction of the coding sequences of unidentified human genes. XV. RT The complete sequences of 100 new cDNA clones from brain which code RT for large proteins in vitro."; RL DNA Res. 6:337-345(1999). RN [3] RP SEQUENCE REVISION. RX MEDLINE=22158633; PubMed=12168954; DOI=10.1093/dnares/9.3.99; RA Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.; RT "Construction of expression-ready cDNA clones for KIAA genes: manual RT curation of 330 KIAA cDNA clones."; RL DNA Res. 9:99-106(2002). CC -!- SUBCELLULAR LOCATION: Cytoplasm. Endosome; endosomal membrane; CC peripheral membrane protein. Also associated with endosomal CC membranes. CC -!- TISSUE SPECIFICITY: High expression in whole adult brain and CC intermediate expression in all other tissues and specific brain CC regions examined, including fetal brain. CC -!- SIMILARITY: Contains 21 ANK repeats. CC -!- SIMILARITY: Contains 1 BTB (POZ) domain. CC -!- SIMILARITY: Contains 1 FYVE-type zinc finger. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; AB037360; BAA90300.1; -; mRNA. DR EMBL; AB033081; BAA86569.2; ALT_INIT; mRNA. DR UniGene; Hs.513875; -. DR HSSP; Q15075; 1HYJ. DR Ensembl; ENSG00000185722; Homo sapiens. DR HGNC; HGNC:20763; ANKFY1. DR MIM; 607927; gene. DR GO; GO:0010008; C:endosome membrane; ISS. DR GO; GO:0006897; P:endocytosis; ISS. DR InterPro; IPR002110; ANK. DR InterPro; IPR000210; BTB. DR InterPro; IPR013069; BTB_POZ. DR InterPro; IPR000306; Znf_FYVE. DR InterPro; IPR011011; Znf_FYVE_PHD. DR Pfam; PF00023; Ank; 21. DR Pfam; PF00651; BTB; 1. DR Pfam; PF01363; FYVE; 1. DR PRINTS; PR01415; ANKYRIN. DR SMART; SM00248; ANK; 16. DR SMART; SM00225; BTB; 1. DR SMART; SM00064; FYVE; 1. DR PROSITE; PS50297; ANK_REP_REGION; 1. DR PROSITE; PS50088; ANK_REPEAT; 12. DR PROSITE; PS50097; BTB; 1. DR PROSITE; PS50178; ZF_FYVE; 1. KW ANK repeat; Membrane; Metal-binding; Repeat; Zinc; Zinc-finger. FT CHAIN 1 1169 Ankyrin repeat and FYVE domain-containing FT protein 1. FT /FTId=PRO_0000066890. FT DOMAIN 68 130 BTB. FT REPEAT 217 247 ANK 1. FT REPEAT 255 284 ANK 2. FT REPEAT 288 317 ANK 3. FT REPEAT 322 362 ANK 4. FT REPEAT 366 396 ANK 5. FT REPEAT 490 519 ANK 6. FT REPEAT 542 572 ANK 7. FT REPEAT 588 617 ANK 8. FT REPEAT 621 650 ANK 9. FT REPEAT 654 683 ANK 10. FT REPEAT 687 716 ANK 11. FT REPEAT 724 753 ANK 12. FT REPEAT 769 798 ANK 13. FT REPEAT 802 832 ANK 14. FT REPEAT 836 865 ANK 15. FT REPEAT 870 899 ANK 16. FT REPEAT 905 934 ANK 17. FT REPEAT 938 967 ANK 18. FT REPEAT 971 1001 ANK 19. FT REPEAT 1005 1037 ANK 20. FT REPEAT 1043 1072 ANK 21. FT ZN_FING 1104 1164 FYVE-type. FT CONFLICT 1 4 MAEE -> AGGK (in Ref. 2). FT CONFLICT 48 48 E -> K (in Ref. 1). FT CONFLICT 115 115 M -> V (in Ref. 1). FT CONFLICT 207 207 A -> P (in Ref. 1). FT CONFLICT 235 235 F -> S (in Ref. 1). FT CONFLICT 270 270 S -> N (in Ref. 1). FT CONFLICT 283 291 DMVDKSGWS -> AWWPRVLE (in Ref. 1). FT CONFLICT 299 300 RG -> E (in Ref. 1). FT CONFLICT 322 322 A -> C (in Ref. 1). FT CONFLICT 336 337 KK -> RN (in Ref. 1). FT CONFLICT 379 379 N -> D (in Ref. 1). FT CONFLICT 385 385 Q -> H (in Ref. 1). FT CONFLICT 645 645 Q -> R (in Ref. 1). FT CONFLICT 652 654 TQD -> PQA (in Ref. 1). FT CONFLICT 687 687 K -> E (in Ref. 1). FT CONFLICT 713 713 D -> G (in Ref. 1). FT CONFLICT 784 784 Missing (in Ref. 1). FT CONFLICT 795 795 N -> D (in Ref. 1). FT CONFLICT 798 798 A -> P (in Ref. 1). FT CONFLICT 807 807 I -> C (in Ref. 1). FT CONFLICT 827 829 DIH -> ISS (in Ref. 1). FT CONFLICT 835 835 R -> K (in Ref. 1). FT CONFLICT 849 849 N -> D (in Ref. 1). FT CONFLICT 860 860 E -> G (in Ref. 1). FT CONFLICT 874 874 F -> S (in Ref. 1). FT CONFLICT 889 889 F -> S (in Ref. 1). FT CONFLICT 901 901 V -> A (in Ref. 1). FT CONFLICT 905 905 S -> P (in Ref. 1). FT CONFLICT 913 913 A -> V (in Ref. 1). FT CONFLICT 916 916 A -> E (in Ref. 1). FT CONFLICT 933 933 N -> T (in Ref. 1). FT CONFLICT 940 940 Q -> K (in Ref. 1). FT CONFLICT 949 949 Q -> E (in Ref. 1). FT CONFLICT 962 962 G -> A (in Ref. 1). FT CONFLICT 1120 1120 T -> A (in Ref. 1). FT CONFLICT 1157 1157 N -> T (in Ref. 1). SQ SEQUENCE 1169 AA; 128399 MW; 589297CA4ACDDB56 CRC64; MAEEEVAKLE KHLMLLRQEY VKLQKKLAET EKRCALLAAQ ANKESSSESF ISRLLAIVAD LYEQEQYSDL KIKVGDRHIS AHKFVLAARS DSWSLANLSS TKELDLSDAN PEVTMTMLRW IYTDELEFRE DDVFLTELMK LANRFQLQLL RERCEKGVMS LVNVRNCIRF YQTAEELNAS TLMNYCAEII ASHWDDLRKE DFSSMSAQLL YKMIKSKTEY PLHKAIKVER EDVVFLYLIE MDSQLPGKLN EADHNGDLAL DLALSRRLES IATTLVSHKA DVDMVDKSGW SLLHKGIQRG DLFAATFLIK NGAFVNAATL GAQETPLHLV ALYSSKKHSA DVMSEMAQIA EALLQAGANP NMQDSKGRTP LHVSIMAGNE YVFSQLLQCK QLDLELKDHE GSTALWLAVQ HITVSSDQSV NPFEDVPVVN GTSFDENSFA ARLIQRGSHT DAPDTATGNC LLQRAAGAGN EAAALFLATN GAHVNHRNKW GETPLHTACR HGLANLTAEL LQQGANPNLQ TEEALPLPKE AASLTSLADS VHLQTPLHMA IAYNHPDVVS VILEQKANAL HATNNLQIIP DFSLKDSRDQ TVLGLALWTG MHTIAAQLLG SGAAINDTMS DGQTLLHMAI QRQDSKSALF LLEHQADINV RTQDGETALQ LAIRNQLPLV VDAICTRGAD MSVPDEKGNP PLWLALANNL EDIASTLVRH GCDATCWGPG PGGCLQTLLH RAIDENNEPT ACFLIRSGCD VNSPRQPGAN GEGEEEARDG QTPLHLAASW GLEETVQCLL EFGANVNAQD AEGRTPIHVA ISSQHGVIIQ LLVSHPDIHL NVRDRQGLTP FACAMTFKNN KSAEAILKRE SGAAEQVDNK GRNFLHVAVQ NSDIESVLFL ISVHANVNSR VQDASKLTPL HLAVQAGSEI IVRNLLLAGA KVNELTKHRQ TALHLAAQQD LPTICSVLLE NGVDFAAVDE NGNNALHLAV MHGRLNNIRV LLTECTVDAE AFNLRGQSPL HILGQYGKEN AAAIFDLFLE CMPGYPLDKP DADGSTVLLL AYMKGNANLC RAIVRSGARL GVNNNQGVNI FNYQVATKQL LFRLLDMLSK EPPWCDGSYC YECTARFGVT TRKHHCRHCG RLLCHKCSTK EIPIIKFDLN KPVRVCNICF DVLTLGGVS // ID ANFY1_MOUSE STANDARD; PRT; 1169 AA. AC Q810B6; O54807; Q80TG6; Q80UH8; DT 04-AUG-2003, integrated into UniProtKB/Swiss-Prot. DT 01-JUN-2003, sequence version 1. DT 30-MAY-2006, entry version 29. DE Ankyrin repeat and FYVE domain-containing protein 1 (Ankyrin repeats DE hooked to a zinc finger motif). GN Name=Ankfy1; Synonyms=Ankhzn, Kiaa1255; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi; OC Muroidea; Muridae; Murinae; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE, AND SUBCELLULAR LOCATION. RX MEDLINE=99194578; PubMed=10092534; DOI=10.1006/bbrc.1999.0430; RA Ito K., Ishii N., Miyashita A., Tominaga K., Kuriyama H., Maruyama H., RA Shirai M., Naito M., Arakawa M., Kuwano R.; RT "Molecular cloning of a novel 130-kDa cytoplasmic protein, Ankhzn, RT containing ankyrin repeats hooked to a zinc finger motif."; RL Biochem. Biophys. Res. Commun. 257:206-213(1999). RN [2] RP NUCLEOTIDE SEQUENCE (ISOFORMS 1 AND 2), AND SEQUENCE REVISION. RA Maruyama H., Kuriyama H., Ishii N., Ito K., Odani S., Kuwano R.; RT "Genomic organization, alternative splicing, and promoter assay of the RT mouse Ankhzn gene."; RL Submitted (DEC-2002) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 994-1169. RC TISSUE=Brain; RX MEDLINE=22579291; PubMed=12693553; DOI=10.1093/dnares/10.1.35; RA Okazaki N., Kikuno R., Ohara R., Inamoto S., Aizawa H., Yuasa S., RA Nakajima D., Nagase T., Ohara O., Koga H.; RT "Prediction of the coding sequences of mouse homologues of KIAA gene: RT II. The complete nucleotide sequences of 400 mouse KIAA-homologous RT cDNAs identified by screening of terminal sequences of cDNA clones RT randomly sampled from size-fractionated libraries."; RL DNA Res. 10:35-48(2003). CC -!- SUBCELLULAR LOCATION: Cytoplasm. Endosome; endosomal membrane; CC peripheral membrane protein. Also associated with endosomal CC membranes. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q810B6-1; Sequence=Displayed; CC Name=2; CC IsoId=Q810B6-2; Sequence=VSP_007917, VSP_007918; CC -!- SIMILARITY: Contains 21 ANK repeats. CC -!- SIMILARITY: Contains 1 BTB (POZ) domain. CC -!- SIMILARITY: Contains 1 FYVE-type zinc finger. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; AB011370; BAA24980.2; -; mRNA. DR EMBL; AB098329; BAC67211.1; -; mRNA. DR EMBL; AB098157; BAC67389.1; -; Genomic_DNA. DR EMBL; AB098157; BAC67388.1; -; Genomic_DNA. DR EMBL; AK122479; BAC65761.1; -; mRNA. DR UniGene; Mm.10313; -. DR HSSP; Q15075; 1HYJ. DR Ensembl; ENSMUSG00000020790; Mus musculus. DR MGI; MGI:1337008; Ankfy1. DR GO; GO:0010008; C:endosome membrane; IDA. DR GO; GO:0006897; P:endocytosis; NAS. DR InterPro; IPR002110; ANK. DR InterPro; IPR000210; BTB. DR InterPro; IPR013069; BTB_POZ. DR InterPro; IPR000306; Znf_FYVE. DR InterPro; IPR011011; Znf_FYVE_PHD. DR Pfam; PF00023; Ank; 21. DR Pfam; PF00651; BTB; 1. DR Pfam; PF01363; FYVE; 1. DR PRINTS; PR01415; ANKYRIN. DR SMART; SM00248; ANK; 15. DR SMART; SM00225; BTB; 1. DR SMART; SM00064; FYVE; 1. DR PROSITE; PS50297; ANK_REP_REGION; 1. DR PROSITE; PS50088; ANK_REPEAT; 11. DR PROSITE; PS50097; BTB; 1. DR PROSITE; PS50178; ZF_FYVE; 1. KW Alternative splicing; ANK repeat; Membrane; Metal-binding; Repeat; KW Zinc; Zinc-finger. FT CHAIN 1 1169 Ankyrin repeat and FYVE domain-containing FT protein 1. FT /FTId=PRO_0000066891. FT DOMAIN 68 130 BTB. FT REPEAT 217 247 ANK 1. FT REPEAT 255 284 ANK 2. FT REPEAT 288 317 ANK 3. FT REPEAT 322 362 ANK 4. FT REPEAT 366 396 ANK 5. FT REPEAT 490 519 ANK 6. FT REPEAT 542 572 ANK 7. FT REPEAT 588 617 ANK 8. FT REPEAT 621 650 ANK 9. FT REPEAT 654 683 ANK 10. FT REPEAT 687 716 ANK 11. FT REPEAT 724 753 ANK 12. FT REPEAT 769 798 ANK 13. FT REPEAT 802 832 ANK 14. FT REPEAT 836 865 ANK 15. FT REPEAT 870 899 ANK 16. FT REPEAT 905 934 ANK 17. FT REPEAT 938 967 ANK 18. FT REPEAT 971 1001 ANK 19. FT REPEAT 1005 1037 ANK 20. FT REPEAT 1043 1072 ANK 21. FT ZN_FING 1104 1164 FYVE-type. FT VAR_SEQ 392 439 LDLELKDHEGSTALWLAVQYITVSSDQSVNPFEDLPVVNGT FT SFDENSL -> YVGRPGEMQSGCEGGIIRFRAERSRRQHCT FT LAGRPVHHCVFRPVCKPL (in isoform 2). FT /FTId=VSP_007917. FT VAR_SEQ 440 1169 Missing (in isoform 2). FT /FTId=VSP_007918. FT CONFLICT 439 439 L -> F (in Ref. 1; BAC67389). FT CONFLICT 448 448 S -> T (in Ref. 1; BAC67389). FT CONFLICT 502 502 G -> V (in Ref. 1; BAC67389). FT CONFLICT 527 527 L -> V (in Ref. 1; BAC67389). FT CONFLICT 840 840 P -> S (in Ref. 1; BAC67389). SQ SEQUENCE 1169 AA; 128604 MW; A78E5406A0AD0165 CRC64; MAEEEVAKLE KHLMLLRQEY VKLQKKLAET EKRCTLLAAQ ANKENSNESF ISRLLAIVAG LYEQEQYSDL KIKVGDRHIS AHKFVLAARS DSWSLANLSS TEEIDLSDAN PEVTMTIVRW IYTDELEFRE DDVFLTELMK LANRFQLQLL RERCEKGVMS LVNVRNCIRF YQTAEELNAS TLMNYCAEII ASHWDDLRKE DFSSLSAQLL YKMIKSKTEY PLHKAIKVER EDVVFLYLIE MDSQLPGKLN ETDHNGDLAL DLALSRRLES IATTLVSHKA DVDMVDKNGW SLLHKGIQRG DLFASTFLIK NGALVNAATA GAQETPLHLV ALYSPKKYSA DVMSEMAQIA EALLQAGANP NMQDSKGRTP LHLSIMARND CVFSQLLQCK QLDLELKDHE GSTALWLAVQ YITVSSDQSV NPFEDLPVVN GTSFDENSLA ARLIQRGSNT DAPDVMTGNC LLQRAAGAGN EAAALFLATS GAHANHRNKW GETPLHTACR HGLANLTAEL LQQGANPNLQ TEEALTLPKE SPVLMSSADS IYLQTPLHMA IAYNHPDVVS VILEQKANAL HATNNLQIIP DFSLKDSRDQ TVLGLALWTG MHTIAAQLLG SGASINDTMS DGQTLLHMAI QRQDSKSALF LLEHQADINV RTQDGETALQ LAIKHQLPLV VDAICTRGAD MSVPDEKGNP PLWLALASNL EDIASTLVRH GCDATCWGPG PSGCLQTLLH RAVDENNEST ACFLIRSGCD VNSPRQPGTN GEGEEEARDG QTPLHLAASW GLEETVQCLL EFGANVNAQD AEGRTPVHVA ISNQHSVIIQ LLISHPNIEL SVRDRQGLTP FACAMTYKNN KAAEAILKRE SGAAEQVDNK GRNFLHVAVQ NSDIESVLFL ISVQANVNSR VQDASKLTPL HLAVQAGSEI IVRNLLLAGA KVNELTKHRQ TALHLAAQQD LPTICSVLLE NGVDFAAVDE NGNNALHLAV MHGRLNNIRA LLTECTVDAE AFNLRGQSPL HILGQYGKEN AAAIFDLFLE CMPEYPLDKP DAEGNTVLLL AYMKGNANLC RAIVRSGVRL GVNNNQGVNI FNYQVATKQL LFRLLDMLSK EPPWCDGSNC YECTAKFGVT TRKHHCRHCG RLLCHKCSTK EIPIIKFDLN KPVRVCNICF DVLTLGGVS // ID EEA1_HUMAN STANDARD; PRT; 1411 AA. AC Q15075; Q14221; DT 22-AUG-2003, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1996, sequence version 1. DT 16-MAY-2006, entry version 45. DE Early endosome antigen 1 (Endosome-associated protein p162) (Zinc DE finger FYVE domain-containing protein 2). GN Name=EEA1; Synonyms=ZFYVE2; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND SUBCELLULAR LOCATION. RC TISSUE=Cervix carcinoma; RX MEDLINE=95286647; PubMed=7768953; DOI=10.1074/jbc.270.22.13503; RA Mu F.-T., Callaghan J.M., Steele-Mortimer O., Stenmark H., RA Parton R.G., Campbell P.L., McCluskey J., Yeo J.-P., Tock E.P.C., RA Toh B.-H.; RT "EEA1, an early endosome-associated protein. EEA1 is a conserved RT alpha-helical peripheral membrane protein flanked by cysteine RT 'fingers' and contains a calmodulin-binding IQ motif."; RL J. Biol. Chem. 270:13503-13511(1995). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RA Seelig H.P.; RL Submitted (APR-1994) to the EMBL/GenBank/DDBJ databases. RN [3] RP INTERACTION WITH RAB5A. RX MEDLINE=98361239; PubMed=9697774; DOI=10.1038/28879; RA Simonsen A., Lippe R., Christoforidis S., Gaullier J.-M., Brech A., RA Callaghan J.M., Toh B.-H., Murphy C., Zerial M., Stenmark H.; RT "EEA1 links PI(3)K function to Rab5 regulation of endosome fusion."; RL Nature 394:494-498(1998). RN [4] RP INTERACTION WITH RAB5A AND RAB5B. RX MEDLINE=99421752; PubMed=10491193; RA Callaghan J.M., Nixon S., Bucci C., Toh B.-H., Stenmark H.; RT "Direct interaction of EEA1 with Rab5b."; RL Eur. J. Biochem. 265:361-366(1999). RN [5] RP INTERACTION WITH STX6, AND SUBCELLULAR LOCATION. RX MEDLINE=99436077; PubMed=10506127; DOI=10.1074/jbc.274.41.28857; RA Simonsen A., Gaullier J.-M., D'Arrigo A., Stenmark H.; RT "The Rab5 effector EEA1 interacts directly with syntaxin-6."; RL J. Biol. Chem. 274:28857-28860(1999). RN [6] RP MUTAGENESIS OF ASP-1352; ASN-1357; 1367-VAL-THR-1368; ARG-1375 AND RP ARG-1400, HOMODIMERIZATION, AND INTERACTION WITH PHOSPHATIDYLINOSITOL RP 3-PHOSPHATE. RX MEDLINE=99322673; PubMed=10394369; DOI=10.1016/S1097-2765(01)80013-7; RA Kutateladze T.G., Ogburn K.D., Watson W.T., de Beer T., Emr S.D., RA Burd C.G., Overduin M.; RT "Phosphatidylinositol 3-phosphate recognition by the FYVE domain."; RL Mol. Cell 3:805-811(1999). RN [7] RP MUTAGENESIS OF TRP-1349; CYS-1358; PHE-1365; ARG-1370; ARG-1371; RP HIS-1372; HIS-1373; CYS-1374; ARG-1375; CYS-1377; GLY-1378; CYS-1385; RP ARG-1400 AND CYS-1405, SUBCELLULAR LOCATION, AND INTERACTION WITH RP PHOSPHATIDYLINOSITOL 3-PHOSPHATE. RX MEDLINE=20387352; PubMed=10807926; DOI=10.1074/jbc.M906554199; RA Gaullier J.-M., Roenning E., Gillooly D.J., Stenmark H.; RT "Interaction of the EEA1 FYVE finger with phosphatidylinositol 3- RT phosphate and early endosomes. Role of conserved residues."; RL J. Biol. Chem. 275:24595-24600(2000). RN [8] RP INTERACTION WITH RAB22A. RX MEDLINE=21859373; PubMed=11870209; RA Kauppi M., Simonsen A., Bremnes B., Vieira A., Callaghan J.M., RA Stenmark H., Olkkonen V.M.; RT "The small GTPase Rab22 interacts with EEA1 and controls endosomal RT membrane trafficking."; RL J. Cell Sci. 115:899-911(2002). RN [9] RP MUTAGENESIS OF GLU-39; PHE-41; ILE-42; PRO-44; MET-47 AND TYR-60, RP HOMODIMERIZATION, AND INTERACTION WITH RAB5C. RX MEDLINE=22499593; PubMed=12493736; DOI=10.1074/jbc.M211514200; RA Merithew E., Stone C., Eathiraj S., Lambright D.G.; RT "Determinants of Rab5 interaction with the N-terminus of early RT endosome antigen 1."; RL J. Biol. Chem. 278:8494-8500(2003). RN [10] RP X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 1289-1411 IN COMPLEX WITH RP PHOSPHATIDYLINOSITOL 3-PHOSPHATE, AND HOMODIMERIZATION. RX MEDLINE=21617582; PubMed=11741531; DOI=10.1016/S1097-2765(01)00385-9; RA Dumas J.J., Merithew E., Sudharshan E., Rajamani D., Hayes S., RA Lawe D., Corvera S., Lambright D.G.; RT "Multivalent endosome targeting by homodimeric EEA1."; RL Mol. Cell 8:947-958(2001). RN [11] RP STRUCTURE BY NMR OF 1346-1410 ALONE AND IN COMPLEX WITH RP PHOSPHATIDYLINOSITOL 3-PHOSPHATE. RX MEDLINE=21143489; PubMed=11230696; DOI=10.1126/science.291.5509.1793; RA Kutateladze T.G., Overduin M.; RT "Structural mechanism of endosome docking by the FYVE domain."; RL Science 291:1793-1796(2001). CC -!- FUNCTION: Binds phospholipid vesicles containing CC phosphatidylinositol 3-phosphate and participates in endosomal CC trafficking. CC -!- SUBUNIT: Homodimer. Binds STX6. Binds RAB5A, RAB5B, RAB5C and CC RAB22A that have been activated by GTP-binding. CC -!- INTERACTION: CC O15023:kiaa0305; NbExp=1; IntAct=EBI-298113, EBI-298055; CC Q9UL26:RAB22A; NbExp=1; IntAct=EBI-298113, EBI-399456; CC P20339:RAB5A; NbExp=3; IntAct=EBI-298113, EBI-399437; CC P61020:RAB5B; NbExp=1; IntAct=EBI-298113, EBI-399401; CC Q63635:Stx6 (xeno); NbExp=2; IntAct=EBI-298113, EBI-398854; CC O60784:TOM1; NbExp=1; IntAct=EBI-298113, EBI-74634; CC -!- SUBCELLULAR LOCATION: Cytoplasm. Endosome; early endosome; early CC endosomal membrane; peripheral membrane protein. CC -!- DOMAIN: The FYVE-type zinc finger domain mediates interactions CC with phosphatidylinositol 3-phosphate. CC -!- DISEASE: Antibodies against EEA1 are found in sera from patients CC with subacute cutaneous lupus erythematosus and other autoimmune CC diseases. CC -!- SIMILARITY: Contains 1 C2H2-type zinc finger. CC -!- SIMILARITY: Contains 1 FYVE-type zinc finger. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; L40157; AAA79121.1; -; mRNA. DR EMBL; X78998; CAA55632.1; -; mRNA. DR PIR; A57013; A57013. DR UniGene; Hs.567367; -. DR PDB; 1HYI; NMR; A=1347-1411. DR PDB; 1HYJ; NMR; A=1347-1411. DR PDB; 1JOC; X-ray; A/B=1287-1411. DR IntAct; Q15075; -. DR Ensembl; ENSG00000102189; Homo sapiens. DR HGNC; HGNC:3185; EEA1. DR MIM; 605070; gene. DR GO; GO:0005829; C:cytosol; IDA. DR GO; GO:0005769; C:early endosome; IDA. DR GO; GO:0019897; C:extrinsic to plasma membrane; IDA. DR GO; GO:0005624; C:membrane fraction; TAS. DR GO; GO:0005516; F:calmodulin binding; NAS. DR GO; GO:0030742; F:GTP-dependent protein binding; IDA. DR GO; GO:0005545; F:phosphatidylinositol binding; IDA. DR GO; GO:0042803; F:protein homodimerization activity; IDA. DR GO; GO:0008270; F:zinc ion binding; TAS. DR GO; GO:0045022; P:early endosome to late endosome transport; NAS. DR GO; GO:0016189; P:synaptic vesicle to endosome fusion; TAS. DR GO; GO:0006906; P:vesicle fusion; IMP. DR InterPro; IPR007087; Znf_C2H2. DR InterPro; IPR000306; Znf_FYVE. DR Pfam; PF01363; FYVE; 1. DR SMART; SM00064; FYVE; 1. DR PROSITE; PS50178; ZF_FYVE; 1. DR PROSITE; PS00028; ZINC_FINGER_C2H2_1; 1. DR PROSITE; PS50157; ZINC_FINGER_C2H2_2; 1. KW 3D-structure; Antigen; Coiled coil; Metal-binding; Zinc; Zinc-finger. FT CHAIN 1 1411 Early endosome antigen 1. FT /FTId=PRO_0000098706. FT ZN_FING 41 64 C2H2-type. FT ZN_FING 1352 1410 FYVE-type. FT COILED 74 1348 Potential. FT COMPBIAS 397 758 Gln/Glu/Lys-rich. FT COMPBIAS 937 1032 Gln/Glu/Lys-rich. FT COMPBIAS 1093 1231 Glu/Lys-rich. FT MUTAGEN 39 39 E->A: Strongly reduces interaction with FT RAB5C. FT MUTAGEN 41 41 F->A: Strongly reduces interaction with FT RAB5C. FT MUTAGEN 42 42 I->A: Strongly reduces interaction with FT RAB5C. FT MUTAGEN 44 44 P->A: Strongly reduces interaction with FT RAB5C. FT MUTAGEN 47 47 M->A: Strongly reduces interaction with FT RAB5C. FT MUTAGEN 60 60 Y->A: Strongly reduces interaction with FT RAB5C. FT MUTAGEN 1349 1349 W->A: Reduces phosphatidylinositol 3- FT phosphate binding and endosomal location. FT MUTAGEN 1352 1352 D->V: Reduces phosphatidylinositol 3- FT phosphate binding and endosomal location. FT MUTAGEN 1357 1357 N->D: Reduces phosphatidylinositol 3- FT phosphate binding and endosomal location. FT MUTAGEN 1358 1358 C->S: Abolishes phosphatidylinositol 3- FT phosphate binding and endosomal location. FT MUTAGEN 1365 1365 F->A: Strongly reduces FT phosphatidylinositol 3-phosphate binding FT and endosomal location. FT MUTAGEN 1367 1368 VT->EE,GG: Abolishes phosphatidylinositol FT 3-phosphate binding and endosomal FT location. FT MUTAGEN 1370 1370 R->A: Abolishes endosomal location. FT MUTAGEN 1371 1371 R->A: Abolishes phosphatidylinositol 3- FT phosphate binding and endosomal location. FT MUTAGEN 1372 1372 H->A: Abolishes endosomal location. FT MUTAGEN 1373 1373 H->A: Abolishes phosphatidylinositol 3- FT phosphate binding and endosomal location. FT MUTAGEN 1374 1374 C->A: Abolishes phosphatidylinositol 3- FT phosphate binding and endosomal location. FT MUTAGEN 1375 1375 R->G: Abolishes phosphatidylinositol 3- FT phosphate binding and endosomal location. FT MUTAGEN 1377 1377 C->A: Abolishes phosphatidylinositol 3- FT phosphate binding and endosomal location. FT MUTAGEN 1378 1378 G->A: Abolishes phosphatidylinositol 3- FT phosphate binding and endosomal location. FT MUTAGEN 1385 1385 C->A: Abolishes phosphatidylinositol 3- FT phosphate binding and endosomal location. FT MUTAGEN 1400 1400 R->G: Strongly reduces FT phosphatidylinositol 3-phosphate binding FT and abolishes endosomal location. FT MUTAGEN 1405 1405 C->S: Abolishes phosphatidylinositol 3- FT phosphate binding and endosomal location. FT CONFLICT 255 255 C -> S (in Ref. 1). FT CONFLICT 258 259 LQ -> FE (in Ref. 1). FT CONFLICT 277 277 A -> S (in Ref. 1). FT CONFLICT 284 284 A -> R (in Ref. 1). FT CONFLICT 520 520 D -> E (in Ref. 1). FT CONFLICT 575 576 EQ -> DE (in Ref. 1). FT CONFLICT 583 584 KL -> NV (in Ref. 1). FT CONFLICT 680 680 Q -> H (in Ref. 1). FT CONFLICT 1325 1325 Missing (in Ref. 1). FT HELIX 1290 1346 FT HELIX 1352 1354 FT STRAND 1357 1357 FT TURN 1359 1361 FT STRAND 1364 1364 FT STRAND 1367 1369 FT STRAND 1372 1373 FT TURN 1375 1377 FT STRAND 1380 1381 FT HELIX 1383 1385 FT STRAND 1386 1386 FT STRAND 1388 1390 FT TURN 1393 1394 FT STRAND 1396 1397 FT STRAND 1399 1401 FT HELIX 1403 1408 FT TURN 1409 1410 SQ SEQUENCE 1411 AA; 162466 MW; C3B17777FE34B6BD CRC64; MLRRILQRTP GRVGSQGSDL DSSATPINTV DVNNESSSEG FICPQCMKSL GSADELFKHY EAVHDAGNDS GHGGESNLAL KRDDVTLLRQ EVQDLQASLK EEKWYSEELK KELEKYQGLQ QQEAKPDGLV TDSSAELQSL EQQLEEAQTE NFNIKQMKDL FEQKAAQLAT EIADIKSKYD EERSLREAAE QKVTRLTEEL NKEATVIQDL KTELLQRPGI EDVAVLKKEL VQVQTLMDNM TLERERESEK LKDECKKLQS QYASSEATIS QLRSELAKGP QEVAVYVQEL QKLKSSVNEL TQKNQTLTEN LLKKEQDYTK LEEKHNEESV SKKNIQATLH QKDLDCQQLQ SRLSASETSL HRIHVELSEK GEATQKLKEE LSEVETKYQH LKAEFKQLQQ QREEKEQHGL QLQSEINQLH SKLLETERQL GEAHGRLKEQ RQLSSEKLMD KEQQVADLQL KLSRLEEQLK EKVTNSTELQ HQLDKTKQQH QEQQALQQST TAKLREAQND LEQVLRQIGD KDQKIQNLEA LLQKSKENIS LLEKEREDLY AKIQAGEGET AVLNQLQEKN HTLQEQVTQL TEKLKNQSES HKQAQENLHD QVQEQKAHLR AAQDRVLSLE TSVNELNSQL NESKEKVSQL DIQIKAKTEL LLSAEAAKTA QRADLQNHLD TAQNALQDKQ QELNKITTQL DQVTAKLQDK QEHCSQLESH LKEYKEKYLS LEQKTEELEG QIKKLEADSL EVKASKEQAL QDLQQQRQLN TDLELRATEL SKQLEMEKEI VSSTRLDLQK KSEALESIKQ KLTKQEEEKQ ILKQDFETLS QETKIQHEEL NNRIQTTVTE LQKVKMEKEA LMTELSTVKD KLSKVSDSLK NSKSEFEKEN QKGKAAILDL EKTCKELKHQ LQVQMENTLK EQKELKKSLE KEKEASHQLK LELNSMQEQL IQAQNTLKQN EKEEQQLQGN INELKQSSEQ KKKQIEALQG ELKIAVLQKT ELENKLQQQL TQAAQELAAE KEKISVLQNN YEKSQETFKQ LQSDFYGRES ELLATRQDLK SVEEKLSLAQ EDLISNRNQI GNQNKLIQEL KTAKATLEQD SAKKEQQLQE RCKALQDIQK EKSLKEKELV NEKSKLAEIE EIKCRQEKEI TKLNEELKSH KLESIKEITN LKDAKQLLIQ QKLELQGKAD SLKAAVEQEK RNQQILKDQV KKEEEELKKE FIEKEAKLHS EIKEKEVGMK KHEENEAKLT MQITALNENL GTVKKEWQSS QRRVSELEKQ TDDLRGEIAV LEATVQNNQD ERRALLERCL KGEGEIEKLQ TKVLELQRKL DNTTAAVQEL GRENQSLQIK HTQALNRKWA EDNEVQNCMA CGKGFSVTVR RHHCRQCGNI FCAECSAKNA LTPSSKKPVR VCDACFNDLQ G // ID EEA1_MOUSE STANDARD; PRT; 1411 AA. AC Q8BL66; Q6DIC2; DT 22-AUG-2003, integrated into UniProtKB/Swiss-Prot. DT 27-SEP-2005, sequence version 2. DT 16-MAY-2006, entry version 26. DE Early endosome antigen 1. GN Name=Eea1; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi; OC Muroidea; Muridae; Murinae; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=C57BL/6; TISSUE=Brain; RX MEDLINE=22388257; PubMed=12477932; DOI=10.1073/pnas.242603899; RA Strausberg R.L., Feingold E.A., Grouse L.H., Derge J.G., RA Klausner R.D., Collins F.S., Wagner L., Shenmen C.M., Schuler G.D., RA Altschul S.F., Zeeberg B., Buetow K.H., Schaefer C.F., Bhat N.K., RA Hopkins R.F., Jordan H., Moore T., Max S.I., Wang J., Hsieh F., RA Diatchenko L., Marusina K., Farmer A.A., Rubin G.M., Hong L., RA Stapleton M., Soares M.B., Bonaldo M.F., Casavant T.L., Scheetz T.E., RA Brownstein M.J., Usdin T.B., Toshiyuki S., Carninci P., Prange C., RA Raha S.S., Loquellano N.A., Peters G.J., Abramson R.D., Mullahy S.J., RA Bosak S.A., McEwan P.J., McKernan K.J., Malek J.A., Gunaratne P.H., RA Richards S., Worley K.C., Hale S., Garcia A.M., Gay L.J., Hulyk S.W., RA Villalon D.K., Muzny D.M., Sodergren E.J., Lu X., Gibbs R.A., RA Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S., Sanchez A., RA Whiting M., Madan A., Young A.C., Shevchenko Y., Bouffard G.G., RA Blakesley R.W., Touchman J.W., Green E.D., Dickson M.C., RA Rodriguez A.C., Grimwood J., Schmutz J., Myers R.M., RA Butterfield Y.S.N., Krzywinski M.I., Skalska U., Smailus D.E., RA Schnerch A., Schein J.E., Jones S.J.M., Marra M.A.; RT "Generation and initial analysis of more than 15,000 full-length human RT and mouse cDNA sequences."; RL Proc. Natl. Acad. Sci. U.S.A. 99:16899-16903(2002). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-946. RC STRAIN=C57BL/6J; TISSUE=Brain; RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., RA Davis M.J., Wilming L.G., Aidinis V., Allen J.E., RA Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L., RA Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M., RA Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R., RA Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G., RA di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G., RA Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M., RA Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., RA Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., RA Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., RA Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., RA Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J., RA Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L., RA Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K., RA Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P., RA Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O., RA Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G., RA Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M., RA Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., RA Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., RA Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., RA Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K., RA Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., RA Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., RA Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., RA Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., RA Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N., RA Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N., RA Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S., RA Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J., RA Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). CC -!- FUNCTION: Binds phospholipid vesicles containing CC phosphatidylinositol 3-phosphate and participates in endosomal CC trafficking (By similarity). CC -!- SUBUNIT: Homodimer. Binds STX6. Binds RAB5A, RAB5B, RAB5C and CC RAB22A that have been activated by GTP-binding (By similarity). CC -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). Endosome; early CC endosome; early endosomal membrane; peripheral membrane protein CC (By similarity). CC -!- SIMILARITY: Contains 1 C2H2-type zinc finger. CC -!- SIMILARITY: Contains 1 FYVE-type zinc finger. CC -!- CAUTION: Ref.2 sequence differs from that shown due to a stop CC codon in position 105 which was translated as Tyr to extend the CC sequence. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; BC075637; AAH75637.1; -; mRNA. DR EMBL; AK046231; BAC32647.1; ALT_SEQ; mRNA. DR UniGene; Mm.210035; -. DR UniGene; Mm.408385; -. DR SMR; Q8BL66; 1289-1411. DR Ensembl; ENSMUSG00000036499; Mus musculus. DR MGI; MGI:2442192; Eea1. DR GO; GO:0005769; C:early endosome; IDA. DR InterPro; IPR002017; Spectrin. DR InterPro; IPR010989; t-snare. DR InterPro; IPR010978; tRNA_bd_arm. DR InterPro; IPR007087; Znf_C2H2. DR InterPro; IPR000306; Znf_FYVE. DR InterPro; IPR011011; Znf_FYVE_PHD. DR Pfam; PF01363; FYVE; 1. DR SMART; SM00064; FYVE; 1. DR PROSITE; PS50178; ZF_FYVE; 1. DR PROSITE; PS00028; ZINC_FINGER_C2H2_1; 1. DR PROSITE; PS50157; ZINC_FINGER_C2H2_2; 1. KW Coiled coil; Metal-binding; Zinc; Zinc-finger. FT CHAIN 1 1411 Early endosome antigen 1. FT /FTId=PRO_0000098707. FT ZN_FING 41 64 C2H2-type. FT ZN_FING 1352 1410 FYVE-type. FT COILED 78 1348 Potential. FT COMPBIAS 396 706 Gln/Glu/Lys-rich. FT CONFLICT 225 225 V -> I (in Ref. 2). SQ SEQUENCE 1411 AA; 160915 MW; 2365A51EF92019FD CRC64; MFRRILQRTP GRVGSQGSDL DSSATPINTV DVNNESSSEG FICPQCMKSL GSADELFKHY QAVHDAGNDS GHGGEAGLAL TRDDITLLRQ EVQDLQASLK EEKWYSEELK KELEKYQGLQ QQEAKSDGLV TDSSAELQAL EQQLEEAQTE NFNIKQMKDL FEQKAAQLAT EIADIKSKYD EEKSLRAAAE QKVTHLTEDL NKQTTVIQDL KTELLQRPGI EDVAVLKKEL VQVQTLMDNM TLERERESEK LKDECKKLQS EHAHLEATIN QLRSELAKGP QEVAVYVQEI QKLKGSINEL TQKNQNLTEK LQKKDLDYTH LEEKHNEESA SRKTLQASLH QRDLDCQQLQ ARLTASESSL QRAQGELSEK AEAAQKLREE LREVESTRQH LKVEVKQLQQ QREEKEQHGL QLQGEVSQLH CKLLETERQL GEAHGRLKEQ RQLSSEKLME KEQQVADLQL KLSRLEEQLK EKVTNSTELQ HQLEKSKQQH QEQQALQQSA TAKLREAQND LEQVLRQIGD KDQKIQNLEA LLQKGKESVS LLEKEREDLY AKIQAGEGET AVLNQLQEKN HALQQQLTQL TEKLKNQSES HKQAEENLHD QVQEQKAHLR AAQDRVLSLE TSVSELSSQL NESKEKVSQL DIQIKAKTEL LLSAEAAKAA QRADLQNHLD TAQHALQDKQ QELNKVSVQL DQLTAKFQEK QEHCIQLESH LKDHKEKHLS LEQKVEDLEG HIKKLEADAL EVKASKEQAL QSLQQQRQLS TDLELRNAEL SRELQEQEEV VSCTKLDLQN KSEILENIKQ TLTKKEEENV VLKQEFEKLS QDSKTQHKEL GDRMQAAVTE LTAVKAQKDA LLAELSTTKE KLSKVSDSLK NSKSEFEKEN QKGKAAVLDL EKACKELKHQ LQVQAESALK EQEDLKKSLE KEKETSQQLK IELNSVKGEV SQAQNTLKQK EKDEQQLQGT INQLKQSAEQ KKKQIEALQG EVKNAVSQKT VLENKLQQQS SQAAQELAAE KGKLSALQSN YEKCQADLKQ LQSDLYGKES ELLATRQDLK SVEEKLTLAQ EDLISNRNQI GNQNKSIQEL QAAKASLEQD SAKKEALLKE QSKALEDAQR EKSVKEKELV AEKSKLAEME EIKCRQEKEI TKLNEELKSH KQESIKEITN LKDAKQLLIQ QKLELQGRVD SLKAALEQEK ESQQLMREQV KKEEEKRKEE FSEKEAKLHS EIKEKEAGMK KHEENEAKLT MQVTTLNENL GTVKKEWQSS QRRVSELEKQ TDDLRGEIAV LEATVQNNQD ERRALLERCL KGEGEIEKLQ TKALELQRKL DNTTAAVQEL GRENQSLQIK HTQALNRKWA EDNEVQNCMS CGKCFSVTVR RHHCRQCGNI FCAECSTKNA LTPSSKKPVR VCDACFNDLQ G // ID FAB1_SCHPO STANDARD; PRT; 1932 AA. AC O59722; O43072; DT 16-MAY-2003, integrated into UniProtKB/Swiss-Prot. DT 16-MAY-2003, sequence version 2. DT 30-MAY-2006, entry version 40. DE Phosphatidylinositol-4-phosphate 5-kinase fab1 (EC 2.7.1.68) (1- DE phosphatidylinositol-4-phosphate kinase) (PIP5K) (PtdIns(4)P-5-kinase) DE (Diphosphoinositide kinase). GN Name=fab1; Synonyms=ste12; ORFNames=SPBC3E7.01, SPBC6B1.11c; OS Schizosaccharomyces pombe (Fission yeast). OC Eukaryota; Fungi; Ascomycota; Schizosaccharomycetes; OC Schizosaccharomycetales; Schizosaccharomycetaceae; OC Schizosaccharomyces. OX NCBI_TaxID=4896; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND SUBCELLULAR LOCATION. RX MEDLINE=21893055; PubMed=11895483; RA Morishita M., Morimoto F., Kitamura K., Koga T., Fukui Y., Maekawa H., RA Yamashita I., Shimoda C.; RT "Phosphatidylinositol 3-phosphate 5-kinase is required for the RT cellular response to nutritional starvation and mating pheromone RT signals in Schizosaccharomyces pombe."; RL Genes Cells 7:199-215(2002). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=972; RX MEDLINE=21848401; PubMed=11859360; DOI=10.1038/nature724; RA Wood V., Gwilliam R., Rajandream M.A., Lyne M.H., Lyne R., Stewart A., RA Sgouros J.G., Peat N., Hayles J., Baker S.G., Basham D., Bowman S., RA Brooks K., Brown D., Brown S., Chillingworth T., Churcher C.M., RA Collins M., Connor R., Cronin A., Davis P., Feltwell T., Fraser A., RA Gentles S., Goble A., Hamlin N., Harris D.E., Hidalgo J., Hodgson G., RA Holroyd S., Hornsby T., Howarth S., Huckle E.J., Hunt S., Jagels K., RA James K.D., Jones L., Jones M., Leather S., McDonald S., McLean J., RA Mooney P., Moule S., Mungall K.L., Murphy L.D., Niblett D., Odell C., RA Oliver K., O'Neil S., Pearson D., Quail M.A., Rabbinowitsch E., RA Rutherford K.M., Rutter S., Saunders D., Seeger K., Sharp S., RA Skelton J., Simmonds M.N., Squares R., Squares S., Stevens K., RA Taylor K., Taylor R.G., Tivey A., Walsh S.V., Warren T., Whitehead S., RA Woodward J.R., Volckaert G., Aert R., Robben J., Grymonprez B., RA Weltjens I., Vanstreels E., Rieger M., Schaefer M., Mueller-Auer S., RA Gabel C., Fuchs M., Duesterhoeft A., Fritzc C., Holzer E., Moestl D., RA Hilbert H., Borzym K., Langer I., Beck A., Lehrach H., Reinhardt R., RA Pohl T.M., Eger P., Zimmermann W., Wedler H., Wambutt R., Purnelle B., RA Goffeau A., Cadieu E., Dreano S., Gloux S., Lelaure V., Mottier S., RA Galibert F., Aves S.J., Xiang Z., Hunt C., Moore K., Hurst S.M., RA Lucas M., Rochet M., Gaillardin C., Tallada V.A., Garzon A., Thode G., RA Daga R.R., Cruzado L., Jimenez J., Sanchez M., del Rey F., Benito J., RA Dominguez A., Revuelta J.L., Moreno S., Armstrong J., Forsburg S.L., RA Cerutti L., Lowe T., McCombie W.R., Paulsen I., Potashkin J., RA Shpakovski G.V., Ussery D., Barrell B.G., Nurse P.; RT "The genome sequence of Schizosaccharomyces pombe."; RL Nature 415:871-880(2002). CC -!- FUNCTION: Catalyzes the phosphorylation of phosphatidylinositol-4- CC phosphate on the fifth hydroxyl of the myo-inositol ring, to form CC phosphatidylinositol-4,5-biphosphate. Required for survival under CC conditions of nitrogen starvation. May have a role in the CC secretion of pheromone peptides. CC -!- CATALYTIC ACTIVITY: ATP + 1-phosphatidyl-1D-myo-inositol 4- CC phosphate = ADP + 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate. CC -!- SUBCELLULAR LOCATION: Cytoplasm. During cell fusion of opposite CC mating types, migrates to the isthmus. CC -!- SIMILARITY: Contains 1 FYVE-type zinc finger. CC -!- SIMILARITY: Contains 1 PI5K domain. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; AL023534; CAA19005.1; -; Genomic_DNA. DR EMBL; AL021838; CAA17054.1; -; Genomic_DNA. DR PIR; T40375; T40375. DR HSSP; Q960X8; 1DVP. DR GeneDB_Spombe; SPBC3E7.01; -. DR BioCyc; SPOM-XXX-01:SPOM-XXX-01-004849-MONOMER; -. DR GO; GO:0000285; F:1-phosphatidylinositol-3-phosphate 5-kinase...; IGI. DR GO; GO:0006897; P:endocytosis; TAS. DR InterPro; IPR002498; PIP5K. DR InterPro; IPR000306; Znf_FYVE. DR InterPro; IPR011011; Znf_FYVE_PHD. DR PANTHER; PTHR11353; Cpn60/TCP-1; 1. DR Pfam; PF01363; FYVE; 1. DR Pfam; PF01504; PIP5K; 1. DR SMART; SM00064; FYVE; 1. DR SMART; SM00330; PIPKc; 1. DR PROSITE; PS50178; ZF_FYVE; 1. KW Complete proteome; Kinase; Metal-binding; Transferase; Zinc; KW Zinc-finger. FT CHAIN 1 1932 Phosphatidylinositol-4-phosphate 5-kinase FT fab1. FT /FTId=PRO_0000185450. FT ZN_FING 60 119 FYVE-type. SQ SEQUENCE 1932 AA; 220135 MW; B9826516D4504229 CRC64; MSEVETPTAA SPTFPVETSH RLDTLHTSST EQIIKDSENV VHTTLKLPTS TLSREFWMKD ERTNNCSLCE TEFTLFRRKH HCRICGKIIC KYCLKEAPGF IFRLQGSIKV CRPCASILVN NYSRSQLFNH SLNESKNRDL TEQHPFVTLD ELNSNDQVLS SFGDLSSTFE MPNNIHPPEV APMIAIPSSR SNYDSPGWAH HSIFLDWSKR NLDSNVINVE DSESGKYNAL TITNSYDAGP SSVSTDYRPV NFGKVPSYSK LRKNKAFSSA KVSDMYLSAD ERNRLEDFSK GDRGLSFVNL SPNIKATSYD RLSTVINEPF ISRSSSLTDE RGLADSGNSY HHFSDSDDES LFNDGLGLSF HANSAIIKQR QQNVASIQRY GNESYLSNFL KAFLPKTVCD YLFPSSTIPD GLPALIENFN ARVDKVNHPG GTEEPLPYQG KSRASSVVTS SKSTCILPPW ILFSDSFNQL VCTFLGKLLF QMLNDEGVDS PMQWVLCLPK ILLKMALDLG PDIRSGDDID VRSYVKIKKI PGGSIQDCFL VNGVLFSKKA SSKSMDRSLR RPRIALLTFS LDYACDEQRI LSLDLIISQQ EEYIINLVNR ICMLKPNLVF AQGQIPSIAL KYFEEHGVIA FHGLKESVLY DIARCCRADI ISSIDKLSLC PRLGTCGRFQ LRTYVVDENK GLRKTFAILD RCSERLGCTI VLRGADYNQL SKVKKIVELV VLIAYHIKLE CALLRDKFVN MPELFETTYQ SLSRKSLPSF ASTAADKEKS QNHEKKSLNS DNQSLRPLEN ENQSVSSTQG SNSPLELINN LPASDDYSSI TKALKTRFLT FSPFLSKPLP RLLNQVNYYQ FIRNKLLKDV KLHPYSPTGS FVMKQSENDN VEESYEESYK FFCIDERYHF LEKQWTLYYS HSKLMFSPFS SQRIILLYSI INKETSVPCI GPERCLLEFY RETDCTLGQY IEDSCLNTNV SCGGEYCKTN DMLWHYRSYV HGNSRISVFL ESFSCPVPGL EEKIIMWSYC KFCKKNTHIT VMSEETWKYS FGKYLEFMFY NSQIRDRFEF CDHSVMAQHV HYFGYCNMAL RFQRDLIEIF ELFVPSVTLR NNPSYIKELK EKEYKRLKGV IEKCLSSVAS RINQIKCDWV TDPEKFESCT SEISKFRTLL SSDYTELYSE FDSIYLNSST SDYLSLNSIL RVLQGKMVKW EQRFLDYQRL YLPSYKELSK IAAAQIKKVF LERPLSQTPL DLPETLENTQ IDIYPSFKTE STDDQLEKVT QTNVASNKRV APYADSMANV GSPESDCFSV ATSSDIPKAN IDFTNDISTQ NTFPASPVSN SGFSRQTYPN ISQRQGVNML SHKRKSASTS DRRFVNASST SGMNMPISSS ISAKISSIQN STKYSPRKPI PAKDVRVSSL VRRFEELSLQ LQEKQKRDEE LIKARRKRAL PVVPSKPVVE VFNDLNEAFD DENSEDENGI NDTKENRATE SNFSGVDSMS KERENVSSNE DNSPEAFEDI FGILFKNESG LEEQQNLEPS SQMDKEGSKL PTSGPLADKT SVYRILSAFW NEWNSLNPPP FEFPLQPTEH MFSDSNVIIR EDEPSSLISF TLSSPDYLSK MVEIEDSMDE ALTNQGLQGS TQFKIENLML KPTGTHLKYQ FEEGSARLSC KVFFAEQFSA LRRACGCEET FVTSLARCSL WESSGGKSGS AFLKTFDKKY ILKVLSRLES DSLLNFAPAY FDYISKVFFH ELPTALTKIF GFYRVDIRNP TTGTICKTDI MIMENVFYDE CPSRIFDLKG SMRNRHVEST GKVDEVLLDE NLVELIYESP IFVSEQLKSL LHSCLWNDTL FLSKLNIMDY SLIVGIDYTK KELYVGIIDF IRTYTWDKKL ESWVKEKGLV GRGPEPTIVT PKQYKNRFRK AMDCYILASQ DFETGEGFKF CE // ID FAB1_YEAST STANDARD; PRT; 2278 AA. AC P34756; DT 01-FEB-1994, integrated into UniProtKB/Swiss-Prot. DT 01-FEB-1994, sequence version 1. DT 30-MAY-2006, entry version 57. DE 1-phosphatidylinositol-3-phosphate 5-kinase FAB1 (EC 2.7.1.150) DE (Phosphatidylinositol-3-phosphate 5-kinase) (Type III PIP kinase). GN Name=FAB1; OrderedLocusNames=YFR019W; OS Saccharomyces cerevisiae (Baker's yeast). OC Eukaryota; Fungi; Ascomycota; Saccharomycotina; Saccharomycetes; OC Saccharomycetales; Saccharomycetaceae; Saccharomyces. OX NCBI_TaxID=4932; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX MEDLINE=95392039; PubMed=7663021; RA Yamamoto A., Dewald D.B., Boronenkov I.V., Anderson R.A., Emr S.D., RA Koshland D.; RT "Novel PI(4)P 5-kinase homologue, Fab1p, essential for normal vacuole RT function and morphology in yeast."; RL Mol. Biol. Cell 6:525-539(1995). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=S288c / AB972; RX MEDLINE=95400292; PubMed=7670463; DOI=10.1038/ng0795-261; RA Murakami Y., Naitou M., Hagiwara H., Shibata T., Ozawa M., RA Sasanuma S., Sasanuma M., Tsuchiya Y., Soeda E., Yokoyama K., RA Yamazaki M., Tashiro H., Eki T.; RT "Analysis of the nucleotide sequence of chromosome VI from RT Saccharomyces cerevisiae."; RL Nat. Genet. 10:261-268(1995). RN [3] RP FUNCTION, AND CATALYTIC ACTIVITY. RX MEDLINE=99035548; PubMed=9811604; DOI=10.1016/S0960-9822(07)00513-1; RA Cooke F.T., Dove S.K., McEwen R.K., Painter G., Holmes A.B., RA Hall M.N., Michell R.H., Parker P.J.; RT "The stress-activated phosphatidylinositol 3-phosphate 5-kinase Fab1p RT is essential for vacuole function in S. cerevisiae."; RL Curr. Biol. 8:1219-1222(1998). RN [4] RP ENZYME REGULATION, AND SUBCELLULAR LOCATION. RX PubMed=11889142; DOI=10.1083/jcb.200201002; RA Bonangelino C.J., Nau J.J., Duex J.E., Brinkman M., Wurmser A.E., RA Gary J.D., Emr S.D., Weisman L.S.; RT "Osmotic stress-induced increase of phosphatidylinositol 3,5- RT bisphosphate requires Vac14p, an activator of the lipid kinase RT Fab1p."; RL J. Cell Biol. 156:1015-1028(2002). RN [5] RP ENZYME REGULATION. RX PubMed=11950935; DOI=10.1091/mbc.01-10-0498; RA Gary J.D., Sato T.K., Stefan C.J., Bonangelino C.J., Weisman L.S., RA Emr S.D.; RT "Regulation of Fab1 phosphatidylinositol 3-phosphate 5-kinase pathway RT by Vac7 protein and Fig4, a polyphosphoinositide phosphatase family RT member."; RL Mol. Biol. Cell 13:1238-1251(2002). RN [6] RP SUBCELLULAR LOCATION. RX MEDLINE=22923954; PubMed=14562095; DOI=10.1038/nature02026; RA Huh W.-K., Falvo J.V., Gerke L.C., Carroll A.S., Howson R.W., RA Weissman J.S., O'Shea E.K.; RT "Global analysis of protein localization in budding yeast."; RL Nature 425:686-691(2003). RN [7] RP LEVEL OF PROTEIN EXPRESSION. RX MEDLINE=22923965; PubMed=14562106; DOI=10.1038/nature02046; RA Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., RA Dephoure N., O'Shea E.K., Weissman J.S.; RT "Global analysis of protein expression in yeast."; RL Nature 425:737-741(2003). CC -!- FUNCTION: Catalyzes the phosphorylation of phosphatidylinositol-3- CC phosphate on the fifth hydroxyl of the myo-inositol ring, to form CC phosphatidylinositol-3,5-bisphosphate. Required for endocytic- CC vacuolar pathway and nuclear migration. The product of the CC reaction it catalyzes functions as an important regulator of CC vacuole homeostasis perhaps by controlling membrane flux to and/or CC from the vacuole. CC -!- CATALYTIC ACTIVITY: ATP + 1-phosphatidyl-1D-myo-inositol 3- CC phosphate = ADP + 1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate. CC -!- COFACTOR: Magnesium or manganese. CC -!- ENZYME REGULATION: Activated by VAC14 and VAC7. VAC14 acts as a CC specific osmotic response regulator. CC -!- SUBCELLULAR LOCATION: Vacuole; vacuolar membrane; peripheral CC membrane protein. Endosome; endosomal membrane; peripheral CC membrane protein. CC -!- MISCELLANEOUS: Present with 149 molecules/cell. CC -!- SIMILARITY: Contains 1 FYVE-type zinc finger. CC -!- SIMILARITY: Contains 1 PI5K domain. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; U01017; AAA81360.1; -; Genomic_DNA. DR EMBL; D50617; BAA09258.1; -; Genomic_DNA. DR PIR; S56274; S56274. DR HSSP; P40343; 1VFY. DR GermOnline; 140173; -. DR Ensembl; YFR019W; Saccharomyces cerevisiae. DR GenomeReviews; D50617_GR; YFR019W. DR SGD; S000001915; FAB1. DR LinkHub; P34756; -. DR GO; GO:0005739; C:mitochondrion; IDA. DR GO; GO:0005774; C:vacuolar membrane; TAS. DR GO; GO:0000285; F:1-phosphatidylinositol-3-phosphate 5-kinase...; IDA. DR GO; GO:0006644; P:phospholipid metabolism; IGI. DR GO; GO:0006950; P:response to stress; TAS. DR GO; GO:0007033; P:vacuole organization and biogenesis; IMP. DR InterPro; IPR002498; PIP5K. DR InterPro; IPR000306; Znf_FYVE. DR InterPro; IPR011011; Znf_FYVE_PHD. DR PANTHER; PTHR11353; Cpn60/TCP-1; 1. DR Pfam; PF01363; FYVE; 1. DR Pfam; PF01504; PIP5K; 1. DR SMART; SM00064; FYVE; 1. DR SMART; SM00330; PIPKc; 1. DR PROSITE; PS50178; ZF_FYVE; 1. KW Complete proteome; Kinase; Membrane; Metal-binding; Transferase; KW Vacuole; Zinc; Zinc-finger. FT CHAIN 1 2278 1-phosphatidylinositol-3-phosphate 5- FT kinase FAB1. FT /FTId=PRO_0000185451. FT ZN_FING 240 299 FYVE-type. FT COMPBIAS 393 397 Poly-Pro. FT COMPBIAS 571 590 Poly-Asn. FT COMPBIAS 1808 1811 Poly-Thr. FT COMPBIAS 1891 1897 Poly-Gln. FT CONFLICT 2275 2275 R -> W (in Ref. 2). SQ SEQUENCE 2278 AA; 257420 MW; 1A0A30E13165DE41 CRC64; MSSEEPHASI SFPDGSHVRS SSTGTSSVNT IDATLSRPNY IKKPSLHIMS TSTTSTTTDL VTNPILSNIS VPKISPPTSS SIATATSTSH VTGTASHSNI KANANTSTSV NKKNLPPTTS GRIPSSTIKR YPSRYKPSHS LQLPIKNDSN FKRSSIYASK STVTAIPIRN NRPISMQNSY ARTPDSDHDD VGDEVSSIKS ASSSLTASLS KSFLFAFYNN RKKDKTSNNG VLSKEYWMKD ESSKECFSCG KTFNTFRRKH HCRICGQIFC SSCTLLIDGD RFGCHAKMRV CYNCYEHADT YEDSSDEEND STMQLNEPRS RSRSRSSNTN PYSHSHSHLH LISQDNHNGT DLHDPVAATD NPQQQNEVYL LNDDDVQSIM TSGEDSKLFI STPPPPPKMA IPATKQGGSL EISFDSENDR ALHYQDDNPG RHHHLDSVPT RYTIRDMDNI SHYDTNSNST LRPHYNTNNS TITINNLNNT TSNNSNYNNT NSNSNINNPA HSLRRSIFHY VSSNSVNKDS NNSSATPASS AQSSSILDPA NRIIGNYAHR NYKFKFNYNS KGPSQQNDTA NGNNDNNNNN NNNNNNNNNN SASGIADNNN IPSNDNGTTF TLDKKKRNPL TKSKSTSAYL EYPLNEEDSS EDEGSMSIYS VLNDDHKTDN PIRSMRNSTK SFQRAQASLQ RMRFRRKSKS KHFPNNSKSS IYRDLNFLTN STPNLLSVVS DDNLYDDSSP LQDKASSSAA SRLTDRKFSN SSGSNNNSNS NSNINTDPWK RIASISGFKL KKEKKRELNE VSLLHMHALL KQLLNDQEIS NLQEWITLLD GALRKVLRTI LNARDLNTLD FRQTYVKIKR ISGGSPQNSE YIDGVVFSKA LPSKTMPRHL KNPRILLIMF PLEYQKNNNH FLSIESVFRQ EREYLDKLVS RLKSLHPDII YVGANVSGYA LELLNDSGIV VQFNMKPQVI ERIAKLTEAD IAISVDKLAT NIKMGECETF EVKSYIYGNI SKTYTFLRGC NPELGGTILL RGDSLENLRK IKQVSEFMVY AIFSLKLESS FFNDNFIQLS TDVYLKRAES KKLQVFEGYF ADFLIKFNNR ILTVSPTVDF PIPFLLEKAR GLEKKLIERI NQYESESDLD RQTQLNMLQG LESTITKKHL GNLIKFLHEM EIENLELEFQ KRSRQWEVSY SSSQNLLGTG SHQSITVLYS MVSTKTATPC VGPQIVTIDY FWDSDISIGQ FIENVVGTAR YPCQQGCNGL YLDHYRSYVH GSGKVDVLIE KFQTRLPKLK DIILTWSYCK KCGTSTPILQ ISEKTWNHSF GKYLEVMFWS YKDSVTGIGK CPHDFTKDHV KYFGYNDLVV RLEYSDLEVH ELITPPRKIK WKPHIDIKLK VELYYKILEK INNFYGSVLS RLERIKLDSM TKDKVLSGQA KIIELKSNAT EEQKLMLQDL DTFYADSPCD QHLPLNLVIK SLYDKAVNWN STFAIFAKSY LPSETDISRI TAKQLKKLFY DSSRKDSEDK KSLHDEKAKT RKPEKNELPL EGLKDVEKPK IDSKNTTENR DRTNEPQNAV TITTFKDDTP IIPTSGTSHL TVTPSASSVS SSLTPQTEER PPISRSGTGI SMTHDKSTRP NIRKMSSDSS LCGLASLANE YSKNNKVSKL ATFFDQMHFD ALSKEFELER ERERLQLNKD KYQAIRLQTS TPIVEIYKNV KDAVDEPLHS RSSGNNLSSA NVKTLEAPVG EHSRANNCNP PNLDQNLETE LENSISQWGE NILNPSGKTT ASTHLNSKPV VKETSENPKS IVRESDNSKS EPLPPVITTT TVNKVESTPQ PEKSLLMKTL SNFWADRSAY LWKPLVYPTC PSEHIFTDSD VIIREDEPSS LIAFCLSTSD YRNKMMNLNV QQQQQQQTAE AAPAKTGGNS GGTTQTGDPS VNISPSVSTT SHNKGRDSEI SSLVTTKEGL LNTPPIEGAR DRTPQESQTH SQANLDTLQE LEKIMTKKTA THLRYQFEEG LTVMSCKIFF TEHFDVFRKI CDCQENFIQS LSRCVKWDSN GGKSGSGFLK TLDDRFIIKE LSHAELEAFI KFAPSYFEYM AQAMFHDLPT TLAKVFGFYQ IQVKSSISSS KSYKMDVIIM ENLFYEKKTT RIFDLKGSMR NRHVEQTGKA NEVLLDENMV EYIYESPIHV REYDKKLLRA SVWNDTLFLA KMNVMDYSLV IGIDNEGYTL TVGIIDFIRT FTWDKKLESW VKEKGLVGGA SVIKQPTVVT PRQYKKRFRE AMERYILMVP DPWYREGN // ID FGD1_HUMAN STANDARD; PRT; 961 AA. AC P98174; Q8N4D9; DT 01-OCT-1996, integrated into UniProtKB/Swiss-Prot. DT 01-FEB-2003, sequence version 2. DT 30-MAY-2006, entry version 56. DE FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital DE dysplasia 1 protein) (Zinc finger FYVE domain-containing protein 3) DE (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF). GN Name=FGD1; Synonyms=ZFYVE3; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Craniofacial; RX MEDLINE=95042764; PubMed=7954831; DOI=10.1016/0092-8674(94)90552-5; RA Pasteris N.G., Cadle A., Logie L.J., Porteous M.E.M., Schwartz C.E., RA Stevenson R.E., Glover T.W., Wilroy R.S., Gorski J.L.; RT "Isolation and characterization of the faciogenital dysplasia RT (Aarskog-Scott syndrome) gene: a putative Rho/Rac guanine nucleotide RT exchange factor."; RL Cell 79:669-678(1994). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Brain; RX MEDLINE=22388257; PubMed=12477932; DOI=10.1073/pnas.242603899; RA Strausberg R.L., Feingold E.A., Grouse L.H., Derge J.G., RA Klausner R.D., Collins F.S., Wagner L., Shenmen C.M., Schuler G.D., RA Altschul S.F., Zeeberg B., Buetow K.H., Schaefer C.F., Bhat N.K., RA Hopkins R.F., Jordan H., Moore T., Max S.I., Wang J., Hsieh F., RA Diatchenko L., Marusina K., Farmer A.A., Rubin G.M., Hong L., RA Stapleton M., Soares M.B., Bonaldo M.F., Casavant T.L., Scheetz T.E., RA Brownstein M.J., Usdin T.B., Toshiyuki S., Carninci P., Prange C., RA Raha S.S., Loquellano N.A., Peters G.J., Abramson R.D., Mullahy S.J., RA Bosak S.A., McEwan P.J., McKernan K.J., Malek J.A., Gunaratne P.H., RA Richards S., Worley K.C., Hale S., Garcia A.M., Gay L.J., Hulyk S.W., RA Villalon D.K., Muzny D.M., Sodergren E.J., Lu X., Gibbs R.A., RA Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S., Sanchez A., RA Whiting M., Madan A., Young A.C., Shevchenko Y., Bouffard G.G., RA Blakesley R.W., Touchman J.W., Green E.D., Dickson M.C., RA Rodriguez A.C., Grimwood J., Schmutz J., Myers R.M., RA Butterfield Y.S.N., Krzywinski M.I., Skalska U., Smailus D.E., RA Schnerch A., Schein J.E., Jones S.J.M., Marra M.A.; RT "Generation and initial analysis of more than 15,000 full-length human RT and mouse cDNA sequences."; RL Proc. Natl. Acad. Sci. U.S.A. 99:16899-16903(2002). RN [3] RP FUNCTION. RX PubMed=8969170; DOI=10.1074/jbc.271.52.33169; RA Zheng Y., Fischer D.J., Santos M.F., Tigyi G., Pasteris N.G., RA Gorski J.L., Xu Y.; RT "The faciogenital dysplasia gene product FGD1 functions as a Cdc42Hs- RT specific guanine-nucleotide exchange factor."; RL J. Biol. Chem. 271:33169-33172(1996). RN [4] RP VARIANT AAS HIS-522. RX MEDLINE=20546218; PubMed=11093277; DOI=10.1038/sj.ejhg.5200553; RA Schwartz C.E., Gillessen-Kaesbach G., May M., Cappa M., Gorski J.L., RA Steindl K., Neri G.; RT "Two novel mutations confirm FGD1 is responsible for the Aarskog RT syndrome."; RL Eur. J. Hum. Genet. 8:869-874(2000). RN [5] RP VARIANT AAS GLN-610. RX MEDLINE=20389563; PubMed=10930571; DOI=10.1016/S0014-5793(00)01857-3; RA Orrico A., Galli L., Falciani M., Bracci M., Cavaliere M.L., RA Rinaldi M.M., Musacchio A., Sorrentino V.; RT "A mutation in the pleckstrin homology (PH) domain of the FGD1 gene in RT an Italian family with faciogenital dysplasia (Aarskog-Scott RT syndrome)."; RL FEBS Lett. 478:216-220(2000). RN [6] RP VARIANT NONSYNDROMAL X-LINKED MENTAL RETARDATION LEU-312. RX PubMed=11940089; RA Lebel R.R., May M., Pouls S., Lubs H.A., Stevenson R.E., RA Schwartz C.E.; RT "Non-syndromic X-linked mental retardation associated with a missense RT mutation (P312L) in the FGD1 gene."; RL Clin. Genet. 61:139-145(2002). RN [7] RP VARIANTS AAS ILE-205; ALA-380 AND HIS-443. RX PubMed=14560308; DOI=10.1038/sj.ejhg.5201081; RA Orrico A., Galli L., Cavaliere M.L., Garavelli L., Fryns J.-P., RA Crushell E., Rinaldi M.M., Medeira A., Sorrentino V.; RT "Phenotypic and molecular characterisation of the Aarskog-Scott RT syndrome: a survey of the clinical variability in light of FGD1 RT mutation analysis in 46 patients."; RL Eur. J. Hum. Genet. 12:16-23(2004). CC -!- FUNCTION: Activates CDC42, a member of the Ras-like family of Rho- CC and Rac proteins, by exchanging bound GDP for free GTP. Plays a CC role in regulating the actin cytoskeleton and cell shape. CC -!- SUBUNIT: Interacts with DBNL/ABP1 and CTTN (By similarity). Binds CC CDC42. CC -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). Associated with CC membrane ruffles and lamellipodia (By similarity). CC -!- TISSUE SPECIFICITY: Expressed in fetal heart, brain, lung, kidney CC and placenta. Less expressed in liver; adult heart, brain, lung, CC pancreas and skeletal muscle. CC -!- DISEASE: Defects in FGD1 are the cause of Aarskog-Scott syndrome CC (AAS) [MIM:305400]. This faciogenital dysplasia is a rare CC multisystemic disorder characterized by disproportionately short CC stature, and by facial, skeletal, and urogenital anomalies. CC -!- DISEASE: Defects in FGD1 are a cause of nonsyndromal X-linked CC mental retardation. CC -!- SIMILARITY: Contains 1 DH (DBL-homology) domain. CC -!- SIMILARITY: Contains 1 FYVE-type zinc finger. CC -!- SIMILARITY: Contains 2 PH domains. CC -!- WEB RESOURCE: NAME=GeneReviews; CC URL="http://www.genetests.org/query?gene=FGD1". CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; U11690; AAA57004.1; -; mRNA. DR EMBL; BC034530; AAH34530.1; -; mRNA. DR UniGene; Hs.584507; -. DR HSSP; Q15075; 1HYJ. DR Ensembl; ENSG00000102302; Homo sapiens. DR HGNC; HGNC:3663; FGD1. DR MIM; 305400; gene+phenotype. DR GO; GO:0005794; C:Golgi apparatus; ISS. DR GO; GO:0030027; C:lamellipodium; ISS. DR GO; GO:0001726; C:ruffle; ISS. DR GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; IDA. DR GO; GO:0005515; F:protein binding; ISS. DR GO; GO:0031267; F:small GTPase binding; IDA. DR GO; GO:0030036; P:actin cytoskeleton organization and biogenesis; IDA. DR GO; GO:0007010; P:cytoskeleton organization and biogenesis; ISS. DR GO; GO:0007275; P:development; TAS. DR GO; GO:0046847; P:filopodium formation; IDA. DR GO; GO:0009887; P:organ morphogenesis; TAS. DR GO; GO:0043088; P:regulation of Cdc42 GTPase activity; IDA. DR GO; GO:0008360; P:regulation of cell shape; ISS. DR GO; GO:0007165; P:signal transduction; TAS. DR InterPro; IPR001331; GDS_CDC24. DR InterPro; IPR001849; PH. DR InterPro; IPR011993; PH_type. DR InterPro; IPR000219; RhoGEF. DR InterPro; IPR000306; Znf_FYVE. DR InterPro; IPR011011; Znf_FYVE_PHD. DR Pfam; PF01363; FYVE; 1. DR Pfam; PF00169; PH; 2. DR Pfam; PF00621; RhoGEF; 1. DR SMART; SM00064; FYVE; 1. DR SMART; SM00233; PH; 2. DR SMART; SM00325; RhoGEF; 1. DR PROSITE; PS00741; DH_1; FALSE_NEG. DR PROSITE; PS50010; DH_2; 1. DR PROSITE; PS50003; PH_DOMAIN; 2. DR PROSITE; PS50178; ZF_FYVE; 1. KW Cytoskeleton; Disease mutation; Guanine-nucleotide releasing factor; KW Metal-binding; Repeat; Zinc; Zinc-finger. FT CHAIN 1 961 FYVE, RhoGEF and PH domain-containing FT protein 1. FT /FTId=PRO_0000080940. FT DOMAIN 373 561 DH. FT DOMAIN 590 689 PH 1. FT DOMAIN 821 921 PH 2. FT ZN_FING 730 790 FYVE-type. FT MOTIF 171 179 SH3-binding (Potential). FT MOTIF 179 187 SH3-binding (Potential). FT COMPBIAS 7 330 Pro-rich. FT VARIANT 205 205 S -> I (in AAS). FT /FTId=VAR_019268. FT VARIANT 312 312 P -> L (in nonsyndromal X-linked mental FT retardation). FT /FTId=VAR_019269. FT VARIANT 380 380 E -> A (in AAS). FT /FTId=VAR_019270. FT VARIANT 443 443 R -> H (in AAS). FT /FTId=VAR_019271. FT VARIANT 522 522 R -> H (in AAS). FT /FTId=VAR_015236. FT VARIANT 610 610 R -> Q (in AAS). FT /FTId=VAR_015237. FT CONFLICT 10 23 AGPSEPEHPATNPP -> RRAFGARTPGHEPA (in Ref. FT 1). FT CONFLICT 195 195 A -> G (in Ref. 1). SQ SEQUENCE 961 AA; 106561 MW; 30963F7B9931E45C CRC64; MHGHRAPGGA GPSEPEHPAT NPPGAAPPAC ADSDPGASEP GLLARRGSGS ALGGPLDPQF VGPSDTSLGA APGHRVLPCG PSPQHHRALR FSYHLEGSQP RPGLHQGNRI LVKSLSLDPG QSLEPHPEGP QRLRSDPGPP TETPSQRPSP LKRAPGPKPQ VPPKPSYLQM PRMPPPLEPI PPPPSRPLPA DPRVAKGLAP RAEASPSSAA VSSLIEKFER EPVIVASDRP VPGPSPGPPE PVMLPQPTSQ PPVPQLPEGE ASRCLFLLAP GPRDGEKVPN RDSGIDSISS PSNSEETCFV SDDGPPSHSL CPGPPALASV PVALADPHRP GSQEVDSDLE EEDDEEEEEE KDREIPVPLM ERQESVELTV QQKVFHIANE LLQTEKAYVS RLHLLDQVFC ARLLEEARNR SSFPADVVHG IFSNICSIYC FHQQFLLPEL EKRMEEWDRY PRIGDILQKL APFLKMYGEY VKNFDRAVEL VNTWTERSTQ FKVIIHEVQK EEACGNLTLQ HHMLEPVQRI PRYELLLKDY LLKLPHGSPD SKDAQKSLEL IATAAEHSNA AIRKMERMHK LLKVYELLGG EEDIVSPTKE LIKEGHILKL SAKNGTTQDR YLILFNDRLL YCVPRLRLLG QKFSVRARID VDGMELKESS NLNLPRTFLV SGKQRSLELQ ARTEEEKKDW VQAINSTLLK HEQTLETFKL LNSTNREDED TPPNSPNVDL GKRAPTPIRE KEVTMCMRCQ EPFNSITKRR HHCKACGHVV CGKCSEFRAR LVYDNNRSNR VCTDCYVALH GVPGSSPACS QHTPQRRRSI LEKQASVAAE NSVICSFLHY MEKGGKGWHK AWFVVPENEP LVLYIYGAPQ DVKAQRSLPL IGFEVGPPEA GERPDRRHVF KITQSHLSWY FSPETEELQR RWMAVLGRAG RGDTFCPGPT LSEDREMEEA PVAALGATAE PPESPQTRDK T // ID FGD1_MOUSE STANDARD; PRT; 960 AA. AC P52734; DT 01-OCT-1996, integrated into UniProtKB/Swiss-Prot. DT 01-OCT-1996, sequence version 1. DT 16-MAY-2006, entry version 43. DE FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital DE dysplasia 1 protein homolog) (Zinc finger FYVE domain-containing DE protein 3) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac DE GEF). GN Name=Fgd1; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi; OC Muroidea; Muridae; Murinae; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX MEDLINE=96081343; PubMed=8535076; RA Pasteris N.G., de Gouyon B., Cadle A.B., Campbell K., Herman G.E., RA Gorski J.L.; RT "Cloning and regional localization of the mouse faciogenital dysplasia RT (Fgd1) gene."; RL Mamm. Genome 6:658-661(1995). RN [2] RP FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH DBNL AND CTTN, AND RP MUTAGENESIS OF PRO-159; PRO-162 AND LYS-164. RX PubMed=12913069; DOI=10.1093/hmg/ddg209; RA Hou P., Estrada L., Kinley A.W., Parsons J.T., Vojtek A.B., RA Gorski J.L.; RT "Fgd1, the Cdc42 GEF responsible for faciogenital dysplasia, directly RT interacts with cortactin and mAbp1 to modulate cell shape."; RL Hum. Mol. Genet. 12:1981-1993(2003). CC -!- FUNCTION: Activates CDC42, a member of the Ras-like family of Rho- CC and Rac proteins, by exchanging bound GDP for free GTP. Plays a CC role in regulating the actin cytoskeleton and cell shape. CC -!- SUBUNIT: Interacts with DBNL/ABP1 and CTTN. Binds CDC42 (By CC similarity). CC -!- SUBCELLULAR LOCATION: Cytoplasm. Associated with membrane ruffles CC and lamellipodia. CC -!- SIMILARITY: Contains 1 DH (DBL-homology) domain. CC -!- SIMILARITY: Contains 1 FYVE-type zinc finger. CC -!- SIMILARITY: Contains 2 PH domains. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; U22325; AAA96001.1; -; mRNA. DR UniGene; Mm.219461; -. DR HSSP; Q15075; 1HYJ. DR Ensembl; ENSMUSG00000025265; Mus musculus. DR MGI; MGI:104566; Fgd1. DR GO; GO:0005794; C:Golgi apparatus; IDA. DR GO; GO:0030027; C:lamellipodium; IDA. DR GO; GO:0001726; C:ruffle; IDA. DR GO; GO:0005515; F:protein binding; IPI. DR GO; GO:0007010; P:cytoskeleton organization and biogenesis; IDA. DR GO; GO:0008360; P:regulation of cell shape; IDA. DR InterPro; IPR001331; GDS_CDC24. DR InterPro; IPR001849; PH. DR InterPro; IPR011993; PH_type. DR InterPro; IPR000219; RhoGEF. DR InterPro; IPR000306; Znf_FYVE. DR InterPro; IPR011011; Znf_FYVE_PHD. DR Pfam; PF01363; FYVE; 1. DR Pfam; PF00169; PH; 2. DR Pfam; PF00621; RhoGEF; 1. DR SMART; SM00064; FYVE; 1. DR SMART; SM00233; PH; 2. DR SMART; SM00325; RhoGEF; 1. DR PROSITE; PS00741; DH_1; FALSE_NEG. DR PROSITE; PS50010; DH_2; 1. DR PROSITE; PS50003; PH_DOMAIN; 2. DR PROSITE; PS50178; ZF_FYVE; 1. KW Cytoskeleton; Guanine-nucleotide releasing factor; Metal-binding; KW Repeat; Zinc; Zinc-finger. FT CHAIN 1 960 FYVE, RhoGEF and PH domain-containing FT protein 1. FT /FTId=PRO_0000080941. FT DOMAIN 372 560 DH. FT DOMAIN 589 688 PH 1. FT DOMAIN 820 920 PH 2. FT ZN_FING 729 789 FYVE-type. FT MOTIF 171 179 SH3-binding (Potential). FT MOTIF 179 187 SH3-binding (Potential). FT COMPBIAS 7 330 Pro-rich. FT MUTAGEN 159 159 P->A: Abolishes binding to DBNL. FT MUTAGEN 162 162 P->A: Abolishes binding to DBNL. FT MUTAGEN 164 164 K->E: No effect on binding to DBNL. SQ SEQUENCE 960 AA; 106478 MW; 41C1B84DE490FC51 CRC64; MHGHRVPGGP GPSDPERSAA NTPGAAPLAC ADSDPGALEP GLPVSRGSGT ALGGPLDPQF VGPSDASLGA PPSSRVLPCG PSPQHHRALR FSYHLEGSQP RPGLHQGNRI LVKSLSLDPG QSLEPHPEGP QRLRSDPGPP TEIPGPRPSP LKRAPGPKPQ VPPKPSYLQM PRVLPPPEPI PPPPSRPLPA DPRVAKGLVP RAEASTSSAA VSSLIEKFER EPVIVASDRP APGPCPVPPE PAMLPQPPPQ PTGSQLPEGE ASRCLFLLAP GPRDGEKVPN RDSGIDSISS PSNSEETCFV SDDGPPIHSL CPGPPALASM PVALADPHRP GSQEVDSDLE EEEEEEEEEK EREIPVPPME RQESVELTVQ QKVFHIANEL LQTEKAYVSR LHLLDQVFCA RLLEEARNRS SFPADVVHGI FSNICSIYCF HQQFLLPELE KRMEEWDRYP RIGDILQKLA PFLKMYGEYV KNFDRAVELV NTWTERSTQF KVIIHEVQKE EACRNLTLQH HMLEPVQRIP RYELLLKDYL LKLPHGSPDS KDAQKSLELI ATAAEHSNAA IRKMERMHKL LKVYELLGGE EDIVSPTKEL IKEGHILKLS AKNGTTQDRY LILFNDRLLY CVPRLRLLGQ KFTVRARIDV DGMELKESSN LNMPRTFLVS GKQRSLELQA RTEEEKKDWV QAINSTLLKH EQTLETFKLL NSTNRDDEDT PPNSPNVDLG KRAPTPIREK EVTMCMRCQE PFNSITKRRH HCKACGHVVC GKCSEFRARL IYDNNRSNRV CTDCYVALHG APGSSPACSQ HTPQRRRSIL EKQASVAAEN SVICSFLHYM EKGGKGWHKA WFVVPENEPL VLYIYGAPQD VKAQRSLPLI GFEVGPPEAG ERPDRRHVFK ITQSHLSWYF SPETEELQRR WMAVLGRAGR GDTFCPGPTL SEDKEMEETP VAASGATAEP PEASQTRDKT // ID FGD2_HUMAN STANDARD; PRT; 655 AA. AC Q7Z6J4; Q5T8I1; Q6P6A8; Q6ZNL5; Q8IZ32; Q8N868; Q9H7M2; DT 15-MAR-2005, integrated into UniProtKB/Swiss-Prot. DT 01-OCT-2003, sequence version 1. DT 30-MAY-2006, entry version 21. DE FYVE, RhoGEF and PH domain-containing protein 2 (Zinc finger FYVE DE domain-containing protein 4). GN Name=FGD2; Synonyms=ZFYVE4; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RC TISSUE=Spleen; RX MEDLINE=21082933; PubMed=11214971; DOI=10.1093/dnares/7.6.357; RA Hattori A., Okumura K., Nagase T., Kikuno R., Hirosawa M., Ohara O.; RT "Characterization of long cDNA clones from human adult spleen."; RL DNA Res. 7:357-366(2000). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4 AND 5). RC TISSUE=Spleen; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., RA Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., RA Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., RA Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., RA Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., RA Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., RA Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., RA Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., RA Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., RA Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., RA Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., RA Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., RA Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., RA Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., RA Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., RA Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., RA Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., RA Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., RA Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., RA Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX MEDLINE=22935763; PubMed=14574404; DOI=10.1038/nature02055; RA Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L., RA Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., RA Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R., RA Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S., RA Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J., RA Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P., RA Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y., RA Burford D.C., Burrill W., Burton J., Carder C., Carter N.P., RA Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V., RA Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J., RA Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., RA Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A., RA Frankland J., French L., Garner P., Garnett J., Ghori M.J., RA Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M., RA Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S., RA Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R., RA Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E., RA Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A., RA Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C., RA Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M., RA Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M., RA Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., RA McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., RA Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R., RA Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W., RA Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M., RA Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L., RA Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J., RA Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B., RA Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L., RA Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W., RA Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A., RA Durbin R., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.; RT "The DNA sequence and analysis of human chromosome 6."; RL Nature 425:805-811(2003). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND VARIANT RP HIS-32. RC TISSUE=Blood, Lymph, and Spleen; RX MEDLINE=22388257; PubMed=12477932; DOI=10.1073/pnas.242603899; RA Strausberg R.L., Feingold E.A., Grouse L.H., Derge J.G., RA Klausner R.D., Collins F.S., Wagner L., Shenmen C.M., Schuler G.D., RA Altschul S.F., Zeeberg B., Buetow K.H., Schaefer C.F., Bhat N.K., RA Hopkins R.F., Jordan H., Moore T., Max S.I., Wang J., Hsieh F., RA Diatchenko L., Marusina K., Farmer A.A., Rubin G.M., Hong L., RA Stapleton M., Soares M.B., Bonaldo M.F., Casavant T.L., Scheetz T.E., RA Brownstein M.J., Usdin T.B., Toshiyuki S., Carninci P., Prange C., RA Raha S.S., Loquellano N.A., Peters G.J., Abramson R.D., Mullahy S.J., RA Bosak S.A., McEwan P.J., McKernan K.J., Malek J.A., Gunaratne P.H., RA Richards S., Worley K.C., Hale S., Garcia A.M., Gay L.J., Hulyk S.W., RA Villalon D.K., Muzny D.M., Sodergren E.J., Lu X., Gibbs R.A., RA Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S., Sanchez A., RA Whiting M., Madan A., Young A.C., Shevchenko Y., Bouffard G.G., RA Blakesley R.W., Touchman J.W., Green E.D., Dickson M.C., RA Rodriguez A.C., Grimwood J., Schmutz J., Myers R.M., RA Butterfield Y.S.N., Krzywinski M.I., Skalska U., Smailus D.E., RA Schnerch A., Schein J.E., Jones S.J.M., Marra M.A.; RT "Generation and initial analysis of more than 15,000 full-length human RT and mouse cDNA sequences."; RL Proc. Natl. Acad. Sci. U.S.A. 99:16899-16903(2002). CC -!- FUNCTION: May activate CDC42, a member of the Ras-like family of CC Rho- and Rac proteins, by exchanging bound GDP for free GTP. May CC play a role in regulating the actin cytoskeleton and cell shape CC (By similarity). CC -!- SUBCELLULAR LOCATION: Cytoplasm (Probable). CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=5; CC Name=1; CC IsoId=Q7Z6J4-1; Sequence=Displayed; CC Name=2; CC IsoId=Q7Z6J4-2; Sequence=VSP_013065, VSP_013070, VSP_013072; CC Note=No experimental confirmation available; CC Name=3; CC IsoId=Q7Z6J4-3; Sequence=VSP_013068, VSP_013069; CC Note=No experimental confirmation available; CC Name=4; CC IsoId=Q7Z6J4-4; Sequence=VSP_013066, VSP_013071; CC Note=No experimental confirmation available; CC Name=5; CC IsoId=Q7Z6J4-5; Sequence=VSP_013067, VSP_013068; CC Note=May be due to an intron retention. No experimental CC confirmation available; CC -!- SIMILARITY: Contains 1 DH (DBL-homology) domain. CC -!- SIMILARITY: Contains 1 FYVE-type zinc finger. CC -!- SIMILARITY: Contains 2 PH domains. CC -!- CAUTION: Ref.3 sequence differs from that shown due to erroneous CC gene model prediction. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; AK024456; BAB15746.1; ALT_INIT; mRNA. DR EMBL; AK097230; BAC04982.1; -; mRNA. DR EMBL; AK131079; BAC85129.1; ALT_INIT; mRNA. DR EMBL; AL160264; CAI20471.1; ALT_SEQ; Genomic_DNA. DR EMBL; BC023645; AAH23645.1; -; mRNA. DR EMBL; BC053655; AAH53655.1; -; mRNA. DR EMBL; BC062363; AAH62363.1; -; mRNA. DR UniGene; Hs.509664; -. DR HSSP; Q15075; 1HYJ. DR Ensembl; ENSG00000146192; Homo sapiens. DR HGNC; HGNC:3664; FGD2. DR MIM; 605091; gene. DR GO; GO:0005794; C:Golgi apparatus; ISS. DR GO; GO:0030027; C:lamellipodium; ISS. DR GO; GO:0001726; C:ruffle; ISS. DR GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; ISS. DR GO; GO:0005515; F:protein binding; ISS. DR GO; GO:0031267; F:small GTPase binding; ISS. DR GO; GO:0030036; P:actin cytoskeleton organization and biogenesis; ISS. DR GO; GO:0007010; P:cytoskeleton organization and biogenesis; ISS. DR GO; GO:0046847; P:filopodium formation; ISS. DR GO; GO:0043088; P:regulation of Cdc42 GTPase activity; ISS. DR GO; GO:0008360; P:regulation of cell shape; ISS. DR InterPro; IPR001849; PH. DR InterPro; IPR011993; PH_type. DR InterPro; IPR000219; RhoGEF. DR InterPro; IPR000306; Znf_FYVE. DR InterPro; IPR011011; Znf_FYVE_PHD. DR Pfam; PF01363; FYVE; 1. DR Pfam; PF00169; PH; 2. DR Pfam; PF00621; RhoGEF; 1. DR SMART; SM00064; FYVE; 1. DR SMART; SM00233; PH; 2. DR SMART; SM00325; RhoGEF; 1. DR PROSITE; PS50010; DH_2; 1. DR PROSITE; PS50003; PH_DOMAIN; 2. DR PROSITE; PS50178; ZF_FYVE; 1. KW Alternative splicing; Cytoskeleton; KW Guanine-nucleotide releasing factor; Metal-binding; Polymorphism; KW Repeat; Zinc; Zinc-finger. FT CHAIN 1 655 FYVE, RhoGEF and PH domain-containing FT protein 2. FT /FTId=PRO_0000080942. FT DOMAIN 102 290 DH. FT DOMAIN 319 418 PH 1. FT DOMAIN 544 641 PH 2. FT ZN_FING 458 518 FYVE-type. FT VAR_SEQ 1 423 Missing (in isoform 2). FT /FTId=VSP_013065. FT VAR_SEQ 1 372 Missing (in isoform 4). FT /FTId=VSP_013066. FT VAR_SEQ 1 22 MKGASEEKLASVSNLVTVFENS -> MFPKKARHPGAPALG FT ICTRQPKSTPGTCCCFPCSPGRKPSGLSLLL (in FT isoform 5). FT /FTId=VSP_013067. FT VAR_SEQ 101 104 EPEK -> VPEG (in isoform 3 and isoform FT 5). FT /FTId=VSP_013068. FT VAR_SEQ 105 655 Missing (in isoform 3). FT /FTId=VSP_013069. FT VAR_SEQ 424 442 NETFKAAAQGPEGDIQEQE -> MGGRRSPRAHSCPTPLNP FT Q (in isoform 2). FT /FTId=VSP_013070. FT VAR_SEQ 460 655 MVTMCMRCQEPFNALTRRRHHCRACGYVVCARCSDYRAELK FT YDDNRPNRVCLHCYAFLTGNVLPEAKEDKRRGILEKGSSAT FT PDQSLMCSFLQLIGDKWGKSGPRGWCVIPRDDPLVLYVYAA FT PQDMRAHTSIPLLGYQVTVGPQGDPRVFQLQQSGQLYTFKA FT ETEELKGRWVKAMERAASGWSPSWPNDGDLSD -> HGDHV FT HALPGALQRSDAPSPPLPGLRLCEYSCQHSCLHLRHPGLHL FT HHPGLHLSYLGLRLIHLGLHLPHLGLHLCHLHLSLRGLHLC FT HPGLYLSYLGFHLIHLGFHLIHLGLHLPHLGLYLSHLGLHL FT PHLGFHQCHPGLYLSHLGLYLPYLGLYPPSSGAAVPILAKS FT AGFNQCSPVVLGTSSEPGVCITTSSGPHSTPQEAAVSHFLD FT GKMRPIEVKLLAEGTPEADPMNLPAFLSSFSTTLRPRARKW FT SPVLVEGHLAPHPLRPCPTTSPGPCPLCTHPPRHPLFTRFG FT (in isoform 4). FT /FTId=VSP_013071. FT VAR_SEQ 585 655 DMRAHTSIPLLGYQVTVGPQGDPRVFQLQQSGQLYTFKAET FT EELKGRWVKAMERAASGWSPSWPNDGDLSD -> VRPPPAR FT PPSGPGLPTACV (in isoform 2). FT /FTId=VSP_013072. FT VARIANT 32 32 Q -> H (in dbSNP:831510). FT /FTId=VAR_021491. SQ SEQUENCE 655 AA; 74892 MW; DB60098249C2B340 CRC64; MKGASEEKLA SVSNLVTVFE NSRTPEAAPR GQRLEDVHHR PECRPPESPG PREKTNVGEA VGSEPRTVSR RYLNSLKNKL SSEAWRKSCQ PVTLSGSGTQ EPEKKIVQEL LETEQAYVAR LHLLDQVFFQ ELLKTARSSK AFPEDVVRVI FSNISSIYQF HSQFFLPELQ RRLDDWTANP RIGDVIQKLA PFLKMYSEYV KNFERAAELL ATWTDKSPLF QEVLTRIQSS EASGSLTLQH HMLEPVQRIP RYELLLKEYI QKLPAQAPDQ ADAQKALDMI FSAAQHSNAA ITEMERLQDL WEVYQRLGLE DDIVDPSNTL LREGPVLKIS FRRNDPMERY LFLFNNMLLY CVPRVIQVGA QFQVRTRIDV AGMKVRELMD AEFPHSFLVS GKQRTLELQA RSQEEMISWM QAFQAAIDQI EKRNETFKAA AQGPEGDIQE QELQSEELGL RAPQWVRDKM VTMCMRCQEP FNALTRRRHH CRACGYVVCA RCSDYRAELK YDDNRPNRVC LHCYAFLTGN VLPEAKEDKR RGILEKGSSA TPDQSLMCSF LQLIGDKWGK SGPRGWCVIP RDDPLVLYVY AAPQDMRAHT SIPLLGYQVT VGPQGDPRVF QLQQSGQLYT FKAETEELKG RWVKAMERAA SGWSPSWPND GDLSD // ID FGD2_MOUSE STANDARD; PRT; 655 AA. AC Q8BY35; O88841; Q7TSE3; Q8VDH4; DT 15-MAR-2005, integrated into UniProtKB/Swiss-Prot. DT 01-MAR-2003, sequence version 1. DT 30-MAY-2006, entry version 26. DE FYVE, RhoGEF and PH domain-containing protein 2. GN Name=Fgd2; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi; OC Muroidea; Muridae; Murinae; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY. RC TISSUE=Spleen; RX MEDLINE=99389726; PubMed=10458911; DOI=10.1006/geno.1999.5903; RA Pasteris N.G., Gorski J.L.; RT "Isolation, characterization, and mapping of the mouse and human Fgd2 RT genes, faciogenital dysplasia (FGD1; Aarskog syndrome) gene RT homologues."; RL Genomics 60:57-66(1999). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=C57BL/6J; RA Brathwaite M., Waeltz P., Schlessinger D., Nagaraja R.; RT "Genomic sequence analysis in the mouse t-complex region."; RL Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC STRAIN=C57BL/6J; TISSUE=Thymus; RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., RA Davis M.J., Wilming L.G., Aidinis V., Allen J.E., RA Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L., RA Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M., RA Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R., RA Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G., RA di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G., RA Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M., RA Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., RA Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., RA Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., RA Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., RA Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J., RA Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L., RA Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K., RA Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P., RA Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O., RA Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G., RA Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M., RA Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., RA Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., RA Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., RA Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K., RA Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., RA Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., RA Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., RA Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., RA Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N., RA Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N., RA Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S., RA Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J., RA Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RC STRAIN=Czech II; TISSUE=Mammary gland; RX MEDLINE=22388257; PubMed=12477932; DOI=10.1073/pnas.242603899; RA Strausberg R.L., Feingold E.A., Grouse L.H., Derge J.G., RA Klausner R.D., Collins F.S., Wagner L., Shenmen C.M., Schuler G.D., RA Altschul S.F., Zeeberg B., Buetow K.H., Schaefer C.F., Bhat N.K., RA Hopkins R.F., Jordan H., Moore T., Max S.I., Wang J., Hsieh F., RA Diatchenko L., Marusina K., Farmer A.A., Rubin G.M., Hong L., RA Stapleton M., Soares M.B., Bonaldo M.F., Casavant T.L., Scheetz T.E., RA Brownstein M.J., Usdin T.B., Toshiyuki S., Carninci P., Prange C., RA Raha S.S., Loquellano N.A., Peters G.J., Abramson R.D., Mullahy S.J., RA Bosak S.A., McEwan P.J., McKernan K.J., Malek J.A., Gunaratne P.H., RA Richards S., Worley K.C., Hale S., Garcia A.M., Gay L.J., Hulyk S.W., RA Villalon D.K., Muzny D.M., Sodergren E.J., Lu X., Gibbs R.A., RA Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S., Sanchez A., RA Whiting M., Madan A., Young A.C., Shevchenko Y., Bouffard G.G., RA Blakesley R.W., Touchman J.W., Green E.D., Dickson M.C., RA Rodriguez A.C., Grimwood J., Schmutz J., Myers R.M., RA Butterfield Y.S.N., Krzywinski M.I., Skalska U., Smailus D.E., RA Schnerch A., Schein J.E., Jones S.J.M., Marra M.A.; RT "Generation and initial analysis of more than 15,000 full-length human RT and mouse cDNA sequences."; RL Proc. Natl. Acad. Sci. U.S.A. 99:16899-16903(2002). CC -!- FUNCTION: May activate CDC42, a member of the Ras-like family of CC Rho- and Rac proteins, by exchanging bound GDP for free GTP. May CC play a role in regulating the actin cytoskeleton and cell shape CC (By similarity). CC -!- SUBCELLULAR LOCATION: Cytoplasm (Probable). CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q8BY35-1; Sequence=Displayed; CC Name=2; CC IsoId=Q8BY35-2; Sequence=VSP_013073; CC Note=No experimental confirmation available; CC -!- TISSUE SPECIFICITY: Detected in spleen and lung. CC -!- SIMILARITY: Contains 1 DH (DBL-homology) domain. CC -!- SIMILARITY: Contains 1 FYVE-type zinc finger. CC -!- SIMILARITY: Contains 2 PH domains. CC -!- CAUTION: Ref.1 sequence differs from that shown due to a CC frameshift in position 606. CC -!- CAUTION: Ref.2 (AAP45200) sequence differs from that shown due to CC erroneous gene model prediction. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; AF017368; AAC35430.1; ALT_FRAME; mRNA. DR EMBL; AY301264; AAP45199.1; -; Genomic_DNA. DR EMBL; AY301264; AAP45200.1; ALT_SEQ; Genomic_DNA. DR EMBL; AK042260; BAC31206.1; -; mRNA. DR EMBL; BC021845; AAH21845.1; -; mRNA. DR UniGene; Mm.279187; -. DR HSSP; Q15075; 1HYJ. DR MGI; MGI:1347084; Fgd2. DR InterPro; IPR001849; PH. DR InterPro; IPR011993; PH_type. DR InterPro; IPR000219; RhoGEF. DR InterPro; IPR000306; Znf_FYVE. DR InterPro; IPR011011; Znf_FYVE_PHD. DR Pfam; PF01363; FYVE; 1. DR Pfam; PF00169; PH; 2. DR Pfam; PF00621; RhoGEF; 1. DR SMART; SM00064; FYVE; 1. DR SMART; SM00233; PH; 2. DR SMART; SM00325; RhoGEF; 1. DR PROSITE; PS50010; DH_2; 1. DR PROSITE; PS50003; PH_DOMAIN; 2. DR PROSITE; PS50178; ZF_FYVE; 1. KW Alternative splicing; Cytoskeleton; KW Guanine-nucleotide releasing factor; Metal-binding; Repeat; Zinc; KW Zinc-finger. FT CHAIN 1 655 FYVE, RhoGEF and PH domain-containing FT protein 2. FT /FTId=PRO_0000080943. FT DOMAIN 102 290 DH. FT DOMAIN 319 418 PH 1. FT DOMAIN 544 641 PH 2. FT ZN_FING 458 518 FYVE-type. FT VAR_SEQ 1 194 Missing (in isoform 2). FT /FTId=VSP_013073. FT CONFLICT 39 39 S -> I (in Ref. 1). SQ SEQUENCE 655 AA; 74634 MW; F5272F107A29BDBE CRC64; MERACEKQDS VCNLVAVFEN NRTPGEAPGS HSLEDQPHSP EHQLSLSPEP WEAPPVKEAL KSEFRPVSRT YLSSLKNKLS SGAWRRSCQP GVSPGPETQE PEEKRVVREL LETEQAYVAR LHLLDQVFFQ ELLREAGRSK AFPEDVVKLI FSNISSIYRF HAQFFLPELQ RRVDDWAATP RIGDVIQKLA PFLKMYSEYV KNFERAAELL ATWMDKSQPF QEVVTRIQCS EASSSLTLQH HMLEPVQRIP RYELLLKEYV QKLPAQAPDL EDAQRALDMI FSAAQHSNAA IAEMERLQGL WDVYQRLGLE DDIVDPSNTL LREGPVLKIS FRRSDPMERY LVLFNNMLLY CVPRVLQVGA QFQVRTRIDV AGMKVRELTD AEFPHSFLVS GKQRTLELQA RSRDEMVSWM QACQAAIDQV EKRSETFKAA VQGPQGDTQE PKPQVEELGL RAPQWVRDKM VTMCMRCQEP FNALTRRRHH CRACGYVVCA KCSDYRAELK YDSNRPNRVC LTCYTFLTGN VLPQGKEDKR RGILEKEASA APEQSLVCSF LQLIGDKCSR SLPRSWCVIP RDDPLVLYVY AAPQDTKAHT SIPLLGYQVI SGPQGDPRVF QLQQSGQQYT FKAESVELQG RWVTAIKRAA SGRTPEGPDE EDVSD // ID FGD3_HUMAN STANDARD; PRT; 725 AA. AC Q5JSP0; Q7Z7D9; Q8N5G1; DT 15-MAR-2005, integrated into UniProtKB/Swiss-Prot. DT 15-FEB-2005, sequence version 1. DT 30-MAY-2006, entry version 16. DE FYVE, RhoGEF and PH domain-containing protein 3 (Zinc finger FYVE DE domain-containing protein 5). GN Name=FGD3; Synonyms=ZFYVE5; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2). RA Shan Y.X., Yu L.; RT "Cloning and characterization of a human FGD3 gene: a novel RT faciogenital dysplasia (FGD1; Aarskog syndrome) gene homolog."; RL Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15164053; DOI=10.1038/nature02465; RA Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., RA Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., RA Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S., RA Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R., RA Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P., RA Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W., RA Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G., RA Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M., RA Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W., RA Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A., RA Frankland J.A., French L., Fricker D.G., Garner P., Garnett J., RA Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S., RA Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E., RA Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D., RA Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E., RA Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K., RA Kimberley A.M., King A., Knights A., Laird G.K., Langford C., RA Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., RA Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., RA McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J., RA Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R., RA Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M., RA Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M., RA Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A., RA Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P., RA Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W., RA Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R., RA Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., RA Rogers J., Dunham I.; RT "DNA sequence and analysis of human chromosome 9."; RL Nature 429:369-374(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT RP ILE-275. RC TISSUE=Brain; RX MEDLINE=22388257; PubMed=12477932; DOI=10.1073/pnas.242603899; RA Strausberg R.L., Feingold E.A., Grouse L.H., Derge J.G., RA Klausner R.D., Collins F.S., Wagner L., Shenmen C.M., Schuler G.D., RA Altschul S.F., Zeeberg B., Buetow K.H., Schaefer C.F., Bhat N.K., RA Hopkins R.F., Jordan H., Moore T., Max S.I., Wang J., Hsieh F., RA Diatchenko L., Marusina K., Farmer A.A., Rubin G.M., Hong L., RA Stapleton M., Soares M.B., Bonaldo M.F., Casavant T.L., Scheetz T.E., RA Brownstein M.J., Usdin T.B., Toshiyuki S., Carninci P., Prange C., RA Raha S.S., Loquellano N.A., Peters G.J., Abramson R.D., Mullahy S.J., RA Bosak S.A., McEwan P.J., McKernan K.J., Malek J.A., Gunaratne P.H., RA Richards S., Worley K.C., Hale S., Garcia A.M., Gay L.J., Hulyk S.W., RA Villalon D.K., Muzny D.M., Sodergren E.J., Lu X., Gibbs R.A., RA Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S., Sanchez A., RA Whiting M., Madan A., Young A.C., Shevchenko Y., Bouffard G.G., RA Blakesley R.W., Touchman J.W., Green E.D., Dickson M.C., RA Rodriguez A.C., Grimwood J., Schmutz J., Myers R.M., RA Butterfield Y.S.N., Krzywinski M.I., Skalska U., Smailus D.E., RA Schnerch A., Schein J.E., Jones S.J.M., Marra M.A.; RT "Generation and initial analysis of more than 15,000 full-length human RT and mouse cDNA sequences."; RL Proc. Natl. Acad. Sci. U.S.A. 99:16899-16903(2002). CC -!- FUNCTION: Promotes the formation of filopodia. May activate CDC42, CC a member of the Ras-like family of Rho- and Rac proteins, by CC exchanging bound GDP for free GTP. Plays a role in regulating the CC actin cytoskeleton and cell shape (By similarity). CC -!- SUBCELLULAR LOCATION: Cytoplasm (Probable). CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q5JSP0-1; Sequence=Displayed; CC Name=2; CC IsoId=Q5JSP0-2; Sequence=VSP_013074, VSP_013075; CC Note=No experimental confirmation available; CC -!- SIMILARITY: Contains 1 DH (DBL-homology) domain. CC -!- SIMILARITY: Contains 1 FYVE-type zinc finger. CC -!- SIMILARITY: Contains 2 PH domains. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; AY211386; AAP20645.1; -; mRNA. DR EMBL; AL389924; CAI41117.1; -; Genomic_DNA. DR EMBL; AL451065; CAI41117.1; JOINED; Genomic_DNA. DR EMBL; AL389924; CAI41118.1; -; Genomic_DNA. DR EMBL; AL451065; CAI41118.1; JOINED; Genomic_DNA. DR EMBL; BC032429; AAH32429.1; -; mRNA. DR UniGene; Hs.411081; -. DR PDB; 2COC; NMR; A=605-703. DR HGNC; HGNC:16027; FGD3. DR GO; GO:0005794; C:Golgi apparatus; ISS. DR GO; GO:0030027; C:lamellipodium; ISS. DR GO; GO:0001726; C:ruffle; ISS. DR GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; ISS. DR GO; GO:0005515; F:protein binding; ISS. DR GO; GO:0031267; F:small GTPase binding; ISS. DR GO; GO:0030036; P:actin cytoskeleton organization and biogenesis; ISS. DR GO; GO:0007010; P:cytoskeleton organization and biogenesis; ISS. DR GO; GO:0046847; P:filopodium formation; ISS. DR GO; GO:0043088; P:regulation of Cdc42 GTPase activity; ISS. DR GO; GO:0008360; P:regulation of cell shape; ISS. DR InterPro; IPR001849; PH. DR InterPro; IPR011993; PH_type. DR InterPro; IPR000219; RhoGEF. DR InterPro; IPR000306; Znf_FYVE. DR InterPro; IPR011011; Znf_FYVE_PHD. DR Pfam; PF01363; FYVE; 1. DR Pfam; PF00169; PH; 2. DR Pfam; PF00621; RhoGEF; 1. DR SMART; SM00064; FYVE; 1. DR SMART; SM00233; PH; 2. DR SMART; SM00325; RhoGEF; 1. DR PROSITE; PS50010; DH_2; 1. DR PROSITE; PS50003; PH_DOMAIN; 2. DR PROSITE; PS50178; ZF_FYVE; 1. KW 3D-structure; Alternative splicing; Cytoskeleton; KW Guanine-nucleotide releasing factor; Metal-binding; Polymorphism; KW Repeat; Zinc; Zinc-finger. FT CHAIN 1 725 FYVE, RhoGEF and PH domain-containing FT protein 3. FT /FTId=PRO_0000080944. FT DOMAIN 157 341 DH. FT DOMAIN 370 469 PH 1. FT DOMAIN 604 703 PH 2. FT ZN_FING 532 588 FYVE-type. FT VAR_SEQ 596 634 KTPTADPQPSLLCGPLRLSESGETWSEVWAAIPMSDPQV FT -> VGAPSSCSPPGGAAEPPDTCSCAPAAPAASAFGVSLGP FT G (in isoform 2). FT /FTId=VSP_013074. FT VAR_SEQ 635 725 Missing (in isoform 2). FT /FTId=VSP_013075. FT VARIANT 275 275 V -> I (in dbSNP:3802384). FT /FTId=VAR_021492. SQ SEQUENCE 725 AA; 79401 MW; 665A7FF5BE16B44B CRC64; MESGRGSSTP PGPIAALGMP DTGPGSSSLG KLQALPVGPR AHCGDPVSLA AAGDGSPDIG PTGELSGSLK IPNRDSGIDS PSSSVAGENF PCEEGLEAGP SPTVLGAHAE MALDSQVPKV TPQEEADSDV GEEPDSENTP QKADKDAGLA QHSGPQKLLH IAQELLHTEE TYVKRLHLLD QVFCTRLTDA GIPPEVIMGI FSNISSIHRF HGQFLLPELK TRITEEWDTN PRLGDILQKL APFLKMYGEY VKNFDRAVGL VSTWTQRSPL FKDVVHSIQK QEVCGNLTLQ HHMLEPVQRV PRYELLLKDY LKRLPQDAPD RKDAERSLEL ISTAANHSNA AIRKVEKMHK LLEVYEQLGG EEDIVNPANE LIKEGQIQKL SAKNGTPQDR HLFLFNSMIL YCVPKLRLMG QKFSVREKMD ISGLQVQDIV KPNTAHTFII TGRKRSLELQ TRTEEEKKEW IQIIQATIEK HKQNSETFKA FGGAFSQDED PSLSPDMPIT STSPVEPVVT TEGSSGAAGL EPRKLSSKTR RDKEKQSCKS CGETFNSITK RRHHCKLCGA VICGKCSEFK AENSRQSRVC RDCFLTQPVA PESTEKTPTA DPQPSLLCGP LRLSESGETW SEVWAAIPMS DPQVLHLQGG SQDGRLPRTI PLPSCKLSVP DPEERLDSGH VWKLQWAKQS WYLSASSAEL QQQWLETLST AAHGDTAQDS PGALQLQVPM GAAAP // ID FGD3_MOUSE STANDARD; PRT; 733 AA. AC O88842; Q8BQ72; DT 15-MAR-2005, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1998, sequence version 1. DT 30-MAY-2006, entry version 37. DE FYVE, RhoGEF and PH domain-containing protein 3. GN Name=Fgd3; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi; OC Muroidea; Muridae; Murinae; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE RP SPECIFICITY. RC TISSUE=Spleen; RX MEDLINE=20184742; PubMed=10721717; DOI=10.1016/S0378-1119(99)00518-1; RA Pasteris N.G., Nagata K., Hall A., Gorski J.L.; RT "Isolation, characterization, and mapping of the mouse Fgd3 gene, a RT new faciogenital dysplasia (FGD1; Aarskog syndrome) gene homologue."; RL Gene 242:237-247(2000). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RC STRAIN=C57BL/6J; TISSUE=Spinal ganglion; RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., RA Davis M.J., Wilming L.G., Aidinis V., Allen J.E., RA Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L., RA Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M., RA Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R., RA Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G., RA di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G., RA Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M., RA Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., RA Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., RA Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., RA Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., RA Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J., RA Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L., RA Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K., RA Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P., RA Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O., RA Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G., RA Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M., RA Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., RA Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., RA Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., RA Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K., RA Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., RA Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., RA Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., RA Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., RA Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N., RA Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N., RA Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S., RA Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J., RA Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). CC -!- FUNCTION: Promotes the formation of filopodia. May activate CDC42, CC a member of the Ras-like family of Rho- and Rac proteins, by CC exchanging bound GDP for free GTP. Plays a role in regulating the CC actin cytoskeleton and cell shape. CC -!- SUBCELLULAR LOCATION: Cytoplasm (Probable). CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=O88842-1; Sequence=Displayed; CC Name=2; CC IsoId=O88842-2; Sequence=VSP_013076, VSP_013077; CC Note=No experimental confirmation available; CC -!- TISSUE SPECIFICITY: Detected in adult brain, spleen, lung and CC skeletal muscle. Detected in embryos from E7 to E17. CC -!- SIMILARITY: Contains 1 DH (DBL-homology) domain. CC -!- SIMILARITY: Contains 1 FYVE-type zinc finger. CC -!- SIMILARITY: Contains 2 PH domains. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; AF017369; AAC35431.1; -; mRNA. DR EMBL; AK051395; BAC34624.1; -; mRNA. DR UniGene; Mm.291089; -. DR HSSP; Q15075; 1HYJ. DR Ensembl; ENSMUSG00000037946; Mus musculus. DR MGI; MGI:1353657; Fgd3. DR GO; GO:0046847; P:filopodium formation; IDA. DR InterPro; IPR001849; PH. DR InterPro; IPR011993; PH_type. DR InterPro; IPR000219; RhoGEF. DR InterPro; IPR000306; Znf_FYVE. DR InterPro; IPR011011; Znf_FYVE_PHD. DR Pfam; PF01363; FYVE; 1. DR Pfam; PF00169; PH; 2. DR Pfam; PF00621; RhoGEF; 1. DR SMART; SM00064; FYVE; 1. DR SMART; SM00233; PH; 2. DR SMART; SM00325; RhoGEF; 1. DR PROSITE; PS50010; DH_2; 1. DR PROSITE; PS50003; PH_DOMAIN; 2. DR PROSITE; PS50178; ZF_FYVE; 1. KW Alternative splicing; Cytoskeleton; KW Guanine-nucleotide releasing factor; Metal-binding; Repeat; Zinc; KW Zinc-finger. FT CHAIN 1 733 FYVE, RhoGEF and PH domain-containing FT protein 3. FT /FTId=PRO_0000080945. FT DOMAIN 153 337 DH. FT DOMAIN 366 465 PH 1. FT DOMAIN 612 711 PH 2. FT ZN_FING 528 584 FYVE-type. FT VAR_SEQ 516 532 IESRKSSSKTRRDKEKP -> VSDPHPGISRSERCLGR FT (in isoform 2). FT /FTId=VSP_013076. FT VAR_SEQ 533 733 Missing (in isoform 2). FT /FTId=VSP_013077. FT CONFLICT 7 7 S -> P (in Ref. 2). FT CONFLICT 126 126 V -> M (in Ref. 2). SQ SEQUENCE 733 AA; 80624 MW; 86CDFEBB5DC1E8E3 CRC64; MELGRSSSTP QEEAISPLGV LGTGPSSSPL GKLQALPIGP GAHRGAHSSS APAGDSSTRE PSGAMKIPNR DSGIDSPSSS VASENFPCEE SSEGSPSPAI LGLPSETASD SRVPQDNPQE EEDSGVGEEP DPKVTLFRPQ EDVSLTQCSD PQKLLHIAQE LLHTEEAYVK RLHLLDQVFC TKLTEAGIPL EVTTGIFSNI SSIYRFHGQF LLPELQKRIT EEWDTNPRLG DILQKLAPFL KMYGEYVKNF DRAMGLVSTW TQRSPQFKDV IHTIQKQEVC GNLTLQHHML EPVQRVPRYE LLLKDYLKRL PRDAPDRKDA ERSLELISTA ADHSNAAIRK MEKMHKLLEV YEQLGGEEDI VNPANELIKE GSIQKLSAKN GTTQDRHLFL FNNVMLYCVP KLRLMGQKLS VREKMDISDL QVQDIVKPNA ACTFIITGRK RSLELQTRTE EEKKEWIQVI QATVEKHKQK SETFRAFGGA CSQDEEPTLS PDQPVMSTSS VEPAGVADSN GGTPGIESRK SSSKTRRDKE KPGCKSCGET FNSITKRRYR CKLCGEVICR KCSEFKAENS KQSRVCRECF LEEPLVPPSP SSETPTELKQ NAEKPPSVDP RPSLLCGTLN LSDDGTTWNE VWAAIPESDP QVLDLLAGSQ AGRLLYSIPL SGCNITMPDP EEGLEAGCAW KLHQGSQTWW LSAPSTKLQQ CWLKALGTAV HGDTAGDRPG ASQPQAPAGT DTP // ID FGD3_PONPY STANDARD; PRT; 737 AA. AC Q5R5T1; DT 15-MAR-2005, integrated into UniProtKB/Swiss-Prot. DT 21-DEC-2004, sequence version 1. DT 18-APR-2006, entry version 11. DE FYVE, RhoGEF and PH domain-containing protein 3. GN Name=FGD3; OS Pongo pygmaeus (Orangutan). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Pongo. OX NCBI_TaxID=9600; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Brain cortex; RG The German cDNA consortium; RL Submitted (NOV-2004) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: Promotes the formation of filopodia. May activate CDC42, CC a member of the Ras-like family of Rho- and Rac proteins, by CC exchanging bound GDP for free GTP. Plays a role in regulating the CC actin cytoskeleton and cell shape (By similarity). CC -!- SUBCELLULAR LOCATION: Cytoplasm (Probable). CC -!- SIMILARITY: Contains 1 DH (DBL-homology) domain. CC -!- SIMILARITY: Contains 1 FYVE-type zinc finger. CC -!- SIMILARITY: Contains 2 PH domains. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; CR860772; CAH92885.1; -; mRNA. DR InterPro; IPR001849; PH. DR InterPro; IPR011993; PH_type. DR InterPro; IPR000219; RhoGEF. DR InterPro; IPR000306; Znf_FYVE. DR InterPro; IPR011011; Znf_FYVE_PHD. DR Pfam; PF01363; FYVE; 1. DR Pfam; PF00169; PH; 1. DR Pfam; PF00621; RhoGEF; 1. DR SMART; SM00064; FYVE; 1. DR SMART; SM00233; PH; 2. DR SMART; SM00325; RhoGEF; 1. DR PROSITE; PS50010; DH_2; 1. DR PROSITE; PS50003; PH_DOMAIN; 2. DR PROSITE; PS50178; ZF_FYVE; 1. KW Cytoskeleton; Guanine-nucleotide releasing factor; Metal-binding; KW Repeat; Zinc; Zinc-finger. FT CHAIN 1 737 FYVE, RhoGEF and PH domain-containing FT protein 3. FT /FTId=PRO_0000080946. FT DOMAIN 157 341 DH. FT DOMAIN 370 469 PH 1. FT DOMAIN 616 715 PH 2. FT ZN_FING 532 588 FYVE-type. SQ SEQUENCE 737 AA; 80555 MW; 28C77937884E1923 CRC64; MESGGGSSTP PGPIAALGMP DSGPGSSSLG KLQALPVGPR AHCGDPGSLA AAGDGSLDTG STGELSGSLK IPNRDSGIDS PSSSVAGENF PCEEGLEAGP SPTVLGAHPE MALDSQVPKV TPREEADSDV GEEPDSENTP QKADKDAGLA QHSGPQKLLH IAQELLHTEE TYVKRLHLLD QVFCTRLTDA GIPPEVIMGI FSNISSIHRF HGQFLLPELK TRITEEWDTN PRLGDILQKL APFLKMYGEY VKNFDRAVGL VSTWTQRSPL FKDVVHSIQK QEVCGNLTLQ HHMLEPVQRV PRYELLLKDY LKRLPQDAPD QKDAERSLEL ISTAANHSNA AIRKVEKMHK LLEVYEQLGG EEDIANPANE LIKEGQIQKL SAKNGTPQDR HLFLFNSMIL YCVPKLRLMG QKFSVREKMD ISGLQVQDIV KPNTAHTFII TGRKRSLELQ TRTEEEKKEW IQIIQATIEK HKQNSETFKA FGGAFSQDED PSLSPDMPIT STSPVEPVVT TEGGSGAAGL EPRKLSSKTR RDKEKQSCKS CGETFNSITK RRHHCKLCGV VICGKCSEFK AENSRQSRVC RECFLTQPVA PESPSPEAPA KPRRSTEKTP TADPQPSLLC GPLRLSESGE TWSEVWAAIP MSDPQVLHLQ GGSQDGWLPR TIPLPSCKLS VPDPEERLDS GHVWKLQWAK QSWYLSASSA ELQQRWLETL STAARGDTAQ DSPGALQPQV PTGAAAP // ID FGD4_HUMAN STANDARD; PRT; 766 AA. AC Q96M96; Q6ULS2; Q8TCP6; DT 15-MAR-2005, integrated into UniProtKB/Swiss-Prot. DT 01-DEC-2001, sequence version 1. DT 30-MAY-2006, entry version 27. DE FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament- DE binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc DE finger FYVE domain-containing protein 6). GN Name=FGD4; Synonyms=FRABP, ZFYVE6; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2). RC TISSUE=Testis; RA Lu L., Huang X.Y., Xu M., Yin L.L., Li J.M., Zhou Z.M., Sha J.H.; RT "Cloning a new transcript of actin-filament binding protein frabin in RT testis."; RL Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC TISSUE=Testis; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., RA Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., RA Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., RA Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., RA Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., RA Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., RA Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., RA Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., RA Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., RA Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., RA Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., RA Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., RA Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., RA Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., RA Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., RA Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., RA Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., RA Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., RA Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., RA Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). RC TISSUE=Testis; RG The German cDNA consortium; RL Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases. RN [4] RP FUNCTION. RX PubMed=15133042; DOI=10.1074/jbc.M401592200; RA Chen X.M., Splinter P.L., Tietz P.S., Huang B.Q., Billadeau D.D., RA LaRusso N.F.; RT "Phosphatidylinositol 3-kinase and frabin mediate Cryptosporidium RT parvum cellular invasion via activation of Cdc42."; RL J. Biol. Chem. 279:31671-31678(2004). CC -!- FUNCTION: Activates CDC42, a member of the Ras-like family of Rho- CC and Rac proteins, by exchanging bound GDP for free GTP. Plays a CC role in regulating the actin cytoskeleton and cell shape. CC Activates MAPK8 (By similarity). CC -!- SUBUNIT: Homooligomer (By similarity). CC -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). Concentrated in CC filopodia and poorly detected at lamellipodia. Binds along the CC sides of actin fibers (By similarity). CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=3; CC Name=1; CC IsoId=Q96M96-1; Sequence=Displayed; CC Name=2; CC IsoId=Q96M96-2; Sequence=VSP_013078, VSP_013082; CC Note=No experimental confirmation available; CC Name=3; CC IsoId=Q96M96-3; Sequence=VSP_013079, VSP_013080, VSP_013081; CC Note=No experimental confirmation available; CC -!- DOMAIN: The part of the protein spanning the actin filament- CC binding domain together with the DH domain and the first PH domain CC is necessary and sufficient for microspike formation. Activation CC of MAPK8 requires the presence of all domains with the exception CC of the actin filament-binding domain (By similarity). CC -!- SIMILARITY: Contains 1 DH (DBL-homology) domain. CC -!- SIMILARITY: Contains 1 FYVE-type zinc finger. CC -!- SIMILARITY: Contains 2 PH domains. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; AY367054; AAQ72372.1; -; mRNA. DR EMBL; AK057294; BAB71413.1; -; mRNA. DR EMBL; AL713762; CAD28532.1; -; mRNA. DR UniGene; Hs.117835; -. DR HSSP; Q15075; 1HYJ. DR Ensembl; ENSG00000139132; Homo sapiens. DR HGNC; HGNC:19125; FGD4. DR GO; GO:0005794; C:Golgi apparatus; ISS. DR GO; GO:0030027; C:lamellipodium; ISS. DR GO; GO:0001726; C:ruffle; ISS. DR GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; ISS. DR GO; GO:0005515; F:protein binding; ISS. DR GO; GO:0031267; F:small GTPase binding; ISS. DR GO; GO:0030036; P:actin cytoskeleton organization and biogenesis; ISS. DR GO; GO:0007010; P:cytoskeleton organization and biogenesis; ISS. DR GO; GO:0046847; P:filopodium formation; ISS. DR GO; GO:0043088; P:regulation of Cdc42 GTPase activity; ISS. DR GO; GO:0008360; P:regulation of cell shape; ISS. DR InterPro; IPR001849; PH. DR InterPro; IPR011993; PH_type. DR InterPro; IPR000219; RhoGEF. DR InterPro; IPR000306; Znf_FYVE. DR InterPro; IPR011011; Znf_FYVE_PHD. DR Pfam; PF01363; FYVE; 1. DR Pfam; PF00169; PH; 2. DR Pfam; PF00621; RhoGEF; 1. DR SMART; SM00064; FYVE; 1. DR SMART; SM00233; PH; 2. DR SMART; SM00325; RhoGEF; 1. DR PROSITE; PS50010; DH_2; 1. DR PROSITE; PS50003; PH_DOMAIN; 2. DR PROSITE; PS50178; ZF_FYVE; 1. KW Actin-binding; Alternative splicing; Cytoskeleton; KW Guanine-nucleotide releasing factor; Metal-binding; Repeat; Zinc; KW Zinc-finger. FT CHAIN 1 766 FYVE, RhoGEF and PH domain-containing FT protein 4. FT /FTId=PRO_0000080947. FT DOMAIN 206 393 DH. FT DOMAIN 422 521 PH 1. FT DOMAIN 643 740 PH 2. FT ZN_FING 559 619 FYVE-type. FT REGION 1 150 Actin filament-binding (By similarity). FT VAR_SEQ 1 248 Missing (in isoform 2). FT /FTId=VSP_013078. FT VAR_SEQ 1 30 MEEIKPASASCVSKEKPSKVSDLISRFEGG -> MFSCFLC FT ILSF (in isoform 3). FT /FTId=VSP_013079. FT VAR_SEQ 201 207 ETNEQKL -> VEHETSS (in isoform 3). FT /FTId=VSP_013080. FT VAR_SEQ 208 766 Missing (in isoform 3). FT /FTId=VSP_013081. FT VAR_SEQ 515 766 ALQETIDAFHQRHETFRNAIAKDNDIHSEVSTAELGKRAPR FT WIRDNEVTMCMKCKEPFNALTRRRHHCRACGYVVCWKCSDY FT KAQLEYDGGKLSKVCKDCYQIISGFTDSEEKKRKGILEIES FT AEVSGNSVVCSFLQYMEKSKPWQKAWCVIPKQDPLVLYMYG FT APQDVRAQATIPLLGYVVDEMPRSADLPHSFKLTQSKSVHS FT FAADSEELKQKWLKVILLAVTGETPGGPNEHPATLDDHPEP FT KKKSEC -> RRGFAMLPRLISNS (in isoform 2). FT /FTId=VSP_013082. FT CONFLICT 79 79 A -> T (in Ref. 3). FT CONFLICT 303 303 V -> A (in Ref. 1). SQ SEQUENCE 766 AA; 86596 MW; 125E9B0C008BAE5E CRC64; MEEIKPASAS CVSKEKPSKV SDLISRFEGG SSLSNYSDLK KESAVNLNAP RTPGRHGLTT TPQQKLLSQH LPQRQGNDAD KTQGAQTCVA NGVMAAQNQM ECEEEKAATL SSDTSIQASE PLLDTHIVNG ERDETATAPA SPTTDSCDGN ASDSSYRTPG IGPVLPLEER GAETETKVQE RENGESPLEL EQLDQHHEMK ETNEQKLHKI ANELLLTERA YVNRLDLLDQ VFYCKLLEEA NRGSFPAEMV NKIFSNISSI NAFHSKFLLP ELEKRMQEWE TTPRIGDILQ KLAPFLKMYG EYVKGFDNAM ELVKNMTERI PQFKSVVEEI QKQKICGSLT LQHHMLEPVQ RIPRYEMLLK DYLRKLPPDS LDWNDAKKSL EIISTAASHS NSAIRKMENL KKLLEIYEML GEEEDIVNPS NELIKEGQIL KLAARNTSAQ ERYLFLFNNM LLYCVPKFSL VGSKFTVRTR VGIDGMKIVE TQNEEYPHTF QVSGKERTLE LQASSAQDKE EWIKALQETI DAFHQRHETF RNAIAKDNDI HSEVSTAELG KRAPRWIRDN EVTMCMKCKE PFNALTRRRH HCRACGYVVC WKCSDYKAQL EYDGGKLSKV CKDCYQIISG FTDSEEKKRK GILEIESAEV SGNSVVCSFL QYMEKSKPWQ KAWCVIPKQD PLVLYMYGAP QDVRAQATIP LLGYVVDEMP RSADLPHSFK LTQSKSVHSF AADSEELKQK WLKVILLAVT GETPGGPNEH PATLDDHPEP KKKSEC // ID FGD4_MOUSE STANDARD; PRT; 766 AA. AC Q91ZT5; Q3UEB6; Q8BW60; Q8BZI7; Q91ZT3; Q91ZT4; DT 15-MAR-2005, integrated into UniProtKB/Swiss-Prot. DT 01-DEC-2001, sequence version 1. DT 30-MAY-2006, entry version 29. DE FYVE, RhoGEF and PH domain-containing protein 4 (Actin filement- DE binding protein frabin) (FGD1-related F-actin-binding protein). GN Name=Fgd4; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi; OC Muroidea; Muridae; Murinae; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3), FUNCTION, RP SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY. RC STRAIN=C57BL/6; TISSUE=Brain; RX MEDLINE=21418809; PubMed=11527409; DOI=10.1006/bbrc.2001.5481; RA Ikeda W., Nakanishi H., Takekuni K., Itoh S., Takai Y.; RT "Identification of splicing variants of Frabin with partly different RT functions and tissue distribution."; RL Biochem. Biophys. Res. Commun. 286:1066-1072(2001). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND NUCLEOTIDE RP SEQUENCE [LARGE SCALE MRNA] OF 1-754 (ISOFORM 1). RC STRAIN=C57BL/6J; TISSUE=Bone marrow, Diencephalon, and Oviduct; RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., RA Davis M.J., Wilming L.G., Aidinis V., Allen J.E., RA Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L., RA Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M., RA Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R., RA Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G., RA di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G., RA Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M., RA Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., RA Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., RA Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., RA Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., RA Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J., RA Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L., RA Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K., RA Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P., RA Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O., RA Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G., RA Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M., RA Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., RA Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., RA Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., RA Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K., RA Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., RA Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., RA Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., RA Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., RA Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N., RA Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N., RA Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S., RA Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J., RA Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). RN [3] RP FUNCTION. RX PubMed=10871857; DOI=10.1038/sj.onc.1203631; RA Ono Y., Nakanishi H., Nishimura M., Kakizaki M., Takahashi K., RA Miyahara M., Satoh-Horikawa K., Mandai K., Takai Y.; RT "Two actions of frabin: direct activation of Cdc42 and indirect RT activation of Rac."; RL Oncogene 19:3050-3058(2000). RN [4] RP SUBCELLULAR LOCATION. RX PubMed=11952837; RA Kim Y., Ikeda W., Nakanishi H., Tanaka Y., Takekuni K., Itoh S., RA Monden M., Takai Y.; RT "Association of frabin with specific actin and membrane structures."; RL Genes Cells 7:413-420(2002). CC -!- FUNCTION: Activates CDC42, a member of the Ras-like family of Rho- CC and Rac proteins, by exchanging bound GDP for free GTP. Activates CC MAPK8 (By similarity). Plays a role in regulating the actin CC cytoskeleton and cell shape. Promotes the formation of CC lamellipodia. CC -!- SUBUNIT: Homooligomer (By similarity). CC -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). Concentrated in CC filopodia and poorly detected at lamellipodia. Binds along the CC sides of actin fibers (By similarity). CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=4; CC Name=1; Synonyms=Frabin alpha; CC IsoId=Q91ZT5-1; Sequence=Displayed; CC Name=2; Synonyms=Frabin beta; CC IsoId=Q91ZT5-2; Sequence=VSP_013086, VSP_013087; CC Name=3; Synonyms=Frabin gamma; CC IsoId=Q91ZT5-3; Sequence=VSP_013084, VSP_013085; CC Name=4; CC IsoId=Q91ZT5-4; Sequence=VSP_013083, VSP_013084, VSP_013085; CC Note=No experimental confirmation available; CC -!- TISSUE SPECIFICITY: Detected in brain, thymus, lung, heart, CC skeletal muscle, small intestine, liver, kidney, spleen and CC testis. CC -!- DOMAIN: The part of the protein spanning the actin filament- CC binding domain together with the DH domain and the first PH domain CC is necessary and sufficient for microspike formation. Activation CC of MAPK8 requires the presence of all domains with the exception CC of the actin filament-binding domain (By similarity). CC -!- SIMILARITY: Contains 1 DH (DBL-homology) domain. CC -!- SIMILARITY: Contains 1 FYVE-type zinc finger. CC -!- SIMILARITY: Contains 2 PH domains. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; AF402611; AAL05631.1; -; mRNA. DR EMBL; AF402612; AAL05632.1; -; mRNA. DR EMBL; AF402613; AAL05633.1; -; mRNA. DR EMBL; AK034504; BAC28733.1; -; mRNA. DR EMBL; AK054242; BAC35703.2; -; mRNA. DR EMBL; AK149626; BAE28995.1; -; mRNA. DR UniGene; Mm.256131; -. DR UniGene; Mm.396746; -. DR HSSP; Q15075; 1HYJ. DR IntAct; Q91ZT5; -. DR Ensembl; ENSMUSG00000022788; Mus musculus. DR MGI; MGI:2183747; Fgd4. DR GO; GO:0030175; C:filopodium; IDA. DR GO; GO:0030027; C:lamellipodium; IDA. DR GO; GO:0030032; P:lamellipodium biogenesis; IDA. DR GO; GO:0030035; P:microspike biogenesis; IDA. DR InterPro; IPR001849; PH. DR InterPro; IPR011993; PH_type. DR InterPro; IPR000219; RhoGEF. DR InterPro; IPR000306; Znf_FYVE. DR InterPro; IPR011011; Znf_FYVE_PHD. DR Pfam; PF01363; FYVE; 1. DR Pfam; PF00169; PH; 2. DR Pfam; PF00621; RhoGEF; 1. DR SMART; SM00064; FYVE; 1. DR SMART; SM00233; PH; 2. DR SMART; SM00325; RhoGEF; 1. DR PROSITE; PS50010; DH_2; 1. DR PROSITE; PS50003; PH_DOMAIN; 2. DR PROSITE; PS50178; ZF_FYVE; 1. KW Actin-binding; Alternative splicing; Cytoskeleton; KW Guanine-nucleotide releasing factor; Metal-binding; Repeat; Zinc; KW Zinc-finger. FT CHAIN 1 766 FYVE, RhoGEF and PH domain-containing FT protein 4. FT /FTId=PRO_0000080948. FT DOMAIN 206 393 DH. FT DOMAIN 422 521 PH 1. FT DOMAIN 643 740 PH 2. FT ZN_FING 559 619 FYVE-type. FT REGION 1 150 Actin filament-binding (By similarity). FT VAR_SEQ 1 44 Missing (in isoform 4). FT /FTId=VSP_013083. FT VAR_SEQ 504 504 S -> R (in isoform 3 and isoform 4). FT /FTId=VSP_013084. FT VAR_SEQ 505 766 Missing (in isoform 3 and isoform 4). FT /FTId=VSP_013085. FT VAR_SEQ 589 603 VCWKCSDYKAQLEYD -> SEASSLSQLLEMVYR (in FT isoform 2). FT /FTId=VSP_013086. FT VAR_SEQ 604 766 Missing (in isoform 2). FT /FTId=VSP_013087. FT CONFLICT 36 36 Y -> C (in Ref. 2; BAC35703). FT CONFLICT 49 49 I -> V (in Ref. 2; BAC35703). FT CONFLICT 278 278 E -> K (in Ref. 2; B